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Abstract 
In Neurospora crassa, conidiation is controlled by the circadian clock which consists of 
more than one oscillator. The frequency (frq) gene is a key component in the FRQ oscillator. 
The prd-1 mutant was found to lengthen the period of the circadian rhythm and disrupts the 
FRQ-less rhythm, but how this mutant affects the oscillators was unclear. This thesis aims to 
study the function of the prd-1 gene. Building on previous research, knocking out prd-1 is 
lethal; strains expressing PRD-1-FLAG were constructed; prd-1 expression showed non- 
circadian rhythmicity; co-IP and MS analysis discovered ribosomal proteins bind to PRD-1; 
the prd-1 mutant responds to amino acids differently in growth; and the deletion of the C-
terminus of prd-1 was found to be lethal. The results of these various experiments outlined 
that the prd-1 gene may affect the circadian rhythm via nutrient sensing pathways especially 
the TOR pathway. 
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Chapter 1  Introduction 
Organisms have developed diverse approaches to adapt to the environmental changes on 
the earth. Biological rhythms, oscillations at a biochemical, physiological, or behavioral level, 
are a ubiquitous feature reflecting periodic environmental changes in the world that 
corresponds to the periodic celestial movement: the relative position of Earth to the Sun and 
to the Moon. According to the period of biological rhythms, they can be categorized as 
ultradian (less than 24 h), circadian (about 24 h), infradian (more than 24 h), or even 
circannual rhythms (about one year) (Wollnik, 1989). During the struggle with nature, called 
evolution, organisms gain the endogenous biological clocks which can predict the periodic 
environmental changes such that they can be prepared to optimize their living condition. This 
internal mechanism can maintain the rhythms even in the absence of the environmental 
stimulus.  
1.1 Circadian Rhythms  
1.1.1 History and definitions 
A biological rhythm with a 24-hour period is called a circadian (from Latin circa, “about”; 
di, “day”—i.e., “about a day”) rhythm (Huang et al., 2011; Ishida et al., 1999). The circadian 
rhythms are the most common ones in everyday life and the circadian clock helps regulate 
functions of human bodies including: blood pressure, hormone levels, body temperature, 
appetite, alertness, sleep schedule, and daily performance (Arendt, 2010; Ishida et al., 1999; 
Tsang et al., 2014). Circadian rhythms have been observed in a large number of multi- and 
unicellular organisms, including vertebrates, invertebrates, plants, fungi and bacteria (Dunlap, 
1999; Wollnik, 1989). Such oscillations are believed to be produced by one or multiple 
endogenous oscillators and persist with a period of ∼24 h in the absence of environmental 
time cues. 
The origin of circadian research began with de Mairan in the 18th century, a French 
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scientist who noted the movements of leaves of the sensitive heliotrope plant (probably 
Mimosa pudica) (McClung, 2006), and the daily movements sustained when he moved the 
plant to the constant darkness. More significant, a regular period of the movements was found, 
leading him to a presumption that an endogenous system is controlling the movements. In 
1832 de Candolle measured the free-running period of M. pudica and found it was 22 to 23 
h, notably implying that these rhythms were not simply responses to environmental time cues 
(McClung, 2006). 
In 1954, Colin Pittendrigh showed that eclosion in Drosophila pseudoobscura follows 
the circadian rhythm. The first clock mutant was identified in Drosophila in 1971 by Ron 
Konopka and Seymour Benzer and was called the "period" (per) gene (Golombek and 
Rosenstein, 2010). This gene was cloned in 1984 and scientists began studying the circadian 
rhythm at the molecular level. 
As a mechanism to perceive, predict and adapt to surrounding periodic changes, the 
circadian clock has five fundamental characteristics. Firstly, the circadian clock is 
endogenous. The free running rhythm in constant conditions can be maintained without a 
zeitgeber (German for time givers). Secondly, the circadian clock is stable. The period and 
amplitude of the free running rhythm can stabilize for a relatively long time. Thirdly, the free 
running period is approximately 24 h, but not exactly equal to 24 h. Fourthly, the circadian 
clock can be entrained (synchronized) by external stimuli, like light, temperature or feeding. 
Fifthly, the circadian clock is temperature compensated, which means the free running period 
is substantially unchanged at constant conditions within a certain range of temperatures. 
Typically, the circadian system is conceptualized as a network among three components. 
Input pathways are capable of relaying the environmental signals to timekeeping oscillators; 
the oscillator operates to generate the pace in the absence of the zeitgebers; the output 
pathways are activated transiently and repetitively according to the fluctuation of the core 
oscillator. The entrainment of the circadian rhythm depends on the interaction and 
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synchronization among these three parts. The phase of the circadian rhythm can be reset by 
light pulses, temperature pulses or temperature steps (Lakin-Thomas et al., 1990; Liu et al., 
1997; Liu et al., 2003). The phase alteration is not a simple response to exogenous time cues. 
Different phase alteration responding to the entrainment given at different circadian time 
suggest intricate regulations in the circadian system (Liu, 2003). 
1.1.2 Importance in human health 
The alignment between the clock and physiological events is demonstrated to have great 
significance for organisms particularly for humans.  
Many components of the endocrine system display robust circadian rhythms in mammals 
(Tsang et al., 2014). Several hormones were found to have circadian rhythms: melatonin, 
cortisol, gonadal steroids, prolactin, thyroid hormone and growth hormone (Gnocchi and 
Bruscalupi, 2017). As a hormone helping to adjust the sleep/wake cycle, the timing of 
melatonin secretion is regulated by the suprachiasmatic nucleus (SCN), which is the master 
pacemaker to drive circadian rhythms in mammals (Panda et al., 2002). The secretion begins 
approximately 2 hours before natural sleep time and the concentration of melatonin is highest 
during the middle of the night. Melatonin is also a stable marker of circadian phase used in 
research as well as clinical practice (Golombek and Rosenstein, 2010). 
Organisms are able to use temperature changes as synchronization cues. The changes of 
temperature can induce alterations in the phase response behavior, sometimes even the 
rhythmicity itself (Balzer and Hardeland, 1988). Similarly, scheduled physical activity has 
been reported to phase-shift and entrain the circadian rhythm of rodents. In humans, timed 
physical exercise produced phase-advance shifts. Regular physical exercise also facilitated 
entrainment of the circadian rhythms (Yamanaka et al., 2006). These findings suggest that 
artificial arrangement of the zeitgeber is useful to adjust the circadian rhythm to social 
timetables.  
Numerous reports have shown that shift workers have a higher incidence of diabetes, 
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obesity, and cardiovascular events (Arendt, 2010; Huang et al., 2011). Genome-wide 
association studies have also suggested associations between clock gene variation and 
obesity and metabolic syndrome, implying the impact of the circadian clock on human 
metabolic disease (Huang et al., 2011). Feeding an isocaloric high-fat diet at a deliberately 
altered circadian time results in increased weight gain in mice (Arble et al., 2009), suggesting 
that the synchronization of feeding with the circadian clock is critical in the homeostasis of 
body weight. The disruption of clock genes gives rise to a spectrum of reproductive and 
metabolic changes in animal models. Emerging evidence that mutated or knock-out clock 
genes strongly influence reproductive competency in mice has been found (Boden and 
Kennaway, 2006). 
The discovery of the genetic basis for circadian rhythms has expanded our knowledge 
of the dynamic regulation of behavior and physiology in the human body. More broadly, the 
research about circadian clocks advances the development of clinical practice and 
disseminates the awareness that the synchronization between internal and external time is 
essential for personal welfare. 
1.2 Molecular Circadian Clocks 
1.2.1 Transcription-translation feedback loop (TTFL) 
Circadian clocks are endogenous mechanisms that synchronize physiological and 
behavioral processes in organisms with external time cues. Circadian clocks seem to be the 
fruits of convergent evolution, because the operation principles of circadian clocks share a 
structurally analogous network based on the studies of diverse organism (Czeisler and Gooley, 
2007; Dunlap, 1999) The molecular clocks mentioned here are oscillators that generate the 
intrinsic motivation to drive the circadian rhythms.  
These circadian molecular clocks are composed of transcription–translation feedback 
loops (TTFLs) that are autoregulatory and interlocked. According to this scheme, the clocks 
have a set of components that can positively or negatively modulate the expression of 
5 
relevant genes (Dunlap, 1999). The positive elements activate the transcription of the 
negative elements and clock-controlled genes (ccgs). The negative elements suppress the 
function of the positive elements. The negative elements are translocated and accumulated 
into the nucleus leading to their transcription becoming substantially repressed. Following 
the decay of the negative elements, the transcriptional function of the positive elements is 
renewed (Figure 1.1). The negative feedback with delay is the key to maintain the period. 
The duration of these processes is about 24 hours and the oscillation of the transcriptional 
activity gives rise to the circadian rhythms (Dunlap, 1999; King and Takahashi, 2000). The 
TTFLs are widely accepted as the pacemaker of the circadian clock.  
Regardless of the conservative blueprint, the components of the circadian clock in 
different organisms are distinct. Following are some model systems that are well 
characterized in recent decades.  
Figure 1.1 Schematic diagram of TTFL. The translated protein (negative element) negatively 
regulates the transcription factor (positive element) which causes the rhythmic expression of clock 
and clock-controlled genes. (Adapted from Dunlap, 1999) 
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1.2.2 Molecular circadian clock in Drosophila 
Since the identification of the per mutant and the per gene, several approaches to genetic 
screening have been carried out in Drosophila. Researchers have identified several genes that, 
together with period, play key roles in the circadian clock. For Drosophila, it seems that most 
of the core genes have been identified — new mutant alleles tend to fall into previously 
defined complementation groups (Young and Kay, 2001). The studies of these genes all 
suggest that the TTFL composes a light-responsive molecular clock in Drosophila.  
The rhythmic regulation of the expression of PERIOD (PER) and TIMELESS (TIM) is 
the pivot of these loops (Figure 1.2). Transcription factors CLOCK (CLK) and CYCLE (CYC) 
function as a heterodimer to drive the expression of PER and TIM via the E-boxes in their 
promoter. Once PER and TIM are translated, the casein kinase 1ε orthologue Double-time 
(DBT) binds to either PER or PER/TIM complex and phosphorylates them. The TIM-free 
PER will be degraded and the DBT/PER/TIM complex can enter the nucleus. The gradually 
accumulated PER and TIM can repress the transcriptional activity of CLK/CYC in the 
nucleus while DBT is slowly removed from the DBT/PER/TIM complex (Young and Kay, 
2001). Since the expression of TIM that stabilize PER decreases, the degradation of the 
phosphorylated PER is enhanced. The expression of PER and TIM is reactivated when the 
nuclear PER is at a low level. Delays in PER and TIM accumulation and nuclear translocation 
of the DBT/PER/TIM complex are important for the generation of a 24-hour period 
(Tataroglu and Emery, 2015). The synthesis and degradation of PER and TIM are tightly 
regulated throughout the day to set the pace of the circadian pacemaker (Tataroglu and Emery, 
2015). In general, the abundances of key regulators PER and TIM are tightly regulated by 
the TTFLs to maintain the circadian rhythms in Drosophila. 
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Figure 1.2 The schematic diagram of the TTFL in Drosophila. The CLK/CYC heterodimer binds to 
E-box of the promoter of per/tim and activate the transcription. PER is phosphorylated by DBT and 
TIM binds to phosphorylated PER for stabilization. Then the complex inhibits the activity of 
CLK/CYC in the nucleus and the proteins are degraded when their expression is decreasing. The 
transcriptional activity of CLK/CYC is renewed when the nuclear PER is at a low level and a new 
cycle starts. (Adapted from Tataroglu and Emery, 2015) 
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1.2.3 Molecular circadian clock in mammals 
Many circadian rhythms have been discovered in mammals including blood pressure, 
body temperature, hormone levels, the number of immune cells in blood, and the sleep-wake 
cycle (Ishida et al., 1999). Prior to 1997, no mammalian clock genes had been identified at 
the molecular level (King and Takahashi, 2000). Studies involving mice with mutations that 
possessed aberrant rhythmic phenotypes uncovered clock genes in the 1990s. Researchers 
showed that virtually all cells have the capacity to generate circadian oscillations (Panda et 
al., 2002; Reddy et al., 2006). Further works demonstrated that the mammalian circadian 
system could be conceptualized as a hierarchical system. The master clock, a clock located 
in the suprachiasmatic nuclei (SCN) of the anterior hypothalamus and entrained by light 
signals in the eye (Avivi et al., 2001), synchronizes independent peripheral oscillators 
distributed throughout the body (Steinlechner, 2012).  
At molecular level, the cell-autonomous circadian rhythms in mammals are based on the 
TTFLs (Figure 1.3). The core clock genes identified in mammals are Clock (Circadian 
Locomotor Output Cycles Kaput), Bmal1 (brain and muscle Arnt-like protein 1), Per1 
(Period), Per2, Per3, Cry1 (Cryptochrome), and Cry2. The positive element CLOCK and its 
heterodimeric partner BMAL1, which are basic helix–loop–helix (bHLH)–PER-ARNT-SIM 
(PAS) transcription factors, bind to the promoter of negative elements containing E-boxes 
( PER1, PER2, PER3, CRY1 and CRY2) (Takahashi, 2017). The transcription of PER1, 
PER2, CRY1 and CRY2 are activate in the subjective daytime. Similar with the heterotrimer 
in Drosophila, PER and CRY interact with each other as well as with the CK1δ 
(serine/threonine kinases casein kinase 1δ) and CK1ε in the cytoplasm (Lee et al., 2001). The 
proteins as a complex enter the nucleus at night to repress their own transcription via the 
interaction with transcriptional factors CLOCK-BMAL1. Per and Cry transcription declines 
due to the repression and the PER and CRY protein abundances decrease. PER and CRY 
proteins are subsequently degraded by the proteasome. Once the inhibition is relieved by the 
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turnover of the repressor complex, CLOCK–BMAL1 functions to start a new cycle of 
transcription-translation processes (Takahashi, 2017). Importantly, the mutation of PER2 and 
its regulatory kinase CK1δ, have been found to underlie human sleep-timing disorders 
(Young and Kay, 2001), thus demonstrating a clear role in humans’ circadian clock. 
Beyond targeting Per and Cry, the CLOCK–BMAL1 complex also activates the nuclear 
receptors REV-ERBα and REV-ERBβ (Preitner et al., 2002; Zhang et al., 2015). The 
rhythmic expression of REV-ERBα and REV-ERBβ leads to the repression of BMAL1 and 
CLOCK, which induces a rhythm in these genes that is in antiphase with PER expression 
rhythms (Zhang et al., 2015).  
Figure 1.3 The schematic diagram of the TTFL in mammals. CLOCK and BMAL1 are the positive 
elements that drive expression of the negative regulators, PER1, PER2, CRY1 and CRY2. The PER 
and CRY proteins accumulate and form a complex and are phosphorylated by CKIɛ and glycogen 
synthase kinase-3 (GSK3). They then translocate to the nucleus to repress the positive regulator. At 
the end, the degradation of the PER and CRY proteins releases the repression of the transcription and 
allows the next cycle to start. The activator Rora and the inhibitor Rev-Erbα compose an additional 
stabilizing feedback loop, controls BMAL1 expression and reinforces the oscillations. P, phosphate. 
(Adapted from Gallego and Virshup, 2007) 
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1.2.4 Molecular circadian clock in cyanobacteria 
It was believed that, in rapidly dividing cells (cell cycle significantly shorter than 24 
hours), biological processes would not be coupled to a circadian oscillator (Cohen and 
Golden, 2015). In 1986, Huang and colleagues discovered a circadian rhythm of nitrogen 
fixation and amino acid uptake in Synechococcus sp. RF-1 (Chen et al., 1991; Huang et al., 
1990). Since then the genetically tractable Synechococcus elongatus PCC 7942 has become 
a model organism for studying the molecular mechanism of the clock (Cohen and Golden, 
2015). 
The kaiA, kaiB, and kaiC genes are key genes in the oscillator of S. elongatus. The 
phosphorylation/dephosphorylation cycle caused by the dynamic interactions between these 
three proteins and conformation changes of the proteins are believed to be the core oscillator 
(Figure 1.4). KaiC is an autokinase, autophosphatase, and ATPase. The phosphorylation 
occurs at residues Ser431 and Thr432. (Nishiwaki et al., 2004; Xu et al., 2004). KaiC is a 
ring-shaped homohexamer whose monomer has CI and CII domains that shape the hexamer 
like two stacked doughnuts (Cohen and Golden, 2015). During the subjective daytime, KaiA 
binds to the non-phosphorylated KaiC on its C-terminus, promoting the autophosphorylation 
of KaiC. The phosphorylation of both sites stacks the CII rings on CI rings. The conformation 
change exposes the binding sites for KaiB. KaiB binds to the hyper-phosphorylated KaiC on 
its N-terminus, reactivating the autophosphatase activity of KaiC by sequestrating KaiA away 
from the C-terminus of KaiC. Therefore, in subjective night, the KaiC is auto-
dephosphorylating and again the conformation change exposes the binding sites of KaiA for 
a new cycle (Chang et al., 2012). The KaiABC oscillator transmits the information to the 
output via a pathway consisting of SasA (Synechococcus adaptive sensor A) and RpaA 
(regulator of phycobilisome association A). SasA interacts with the N-terminus of KaiC in 
the same manner as KaiB. The binding induces the phosphorylation of SasA and 
phosphotransfer to the response regulator RpaA (Takai et al., 2006). RpaA is a DNA-binding 
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transcription factor when phosphorylated and binds directly to about 100 targets in the S. 
elongatus genome. The phosphorylated RpaA binds to the kaiBC promoter as well generating 
feedback to the core oscillator (Markson et al., 2013).  
Although not considered as the core oscillator, the TTFL is nonetheless present in the 
cyanobacteria circadian clock. KaiA can positively regulate the expression of kaiBC, whereas 
KaiC is a negative regulator to its own promoter (Ishiura et al., 1998). However, none of the 
Kai proteins are DNA binding proteins. Hence the autoregulatory functions are indirect. This 
TTFL mechanism is not essential for the pacemaker in cyanobacteria because the KaiC 
phosphorylation cycles still can be detected in the test tube or when the TTFL is blocked in 
constant conditions with inhibitors (Tomita et al., 2005). Moreover, evidence showed that the 
TTFL is required under conditions of rapid growth to maintain robust circadian oscillations 
(Cohen and Golden, 2015). 
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Figure 1.4 The schematic diagram of post-translational regulation of the circadian clock in 
cyanobacteria. The progression of the oscillator is shown (indicated by shading from sun to moon at 
the top). During the day (left panel), KaiA interacts with KaiC, promoting the phosphorylation of 
KaiC. Phosphorylation events are indicated by a red dot. SasA interacts with KaiC, promoting 
autophosphorylation of SasA and phosphotransfer to RpaA. RpaA-P accumulates over the day, 
regulating the expression of genes. At night (right panel), KaiA, KaiC, and CikA are all localized to 
the cell poles where fold-switched KaiB competes with SasA for binding to KaiC and sequesters KaiA 
away from the KaiC, promoting KaiC dephosphorylation through the night. CikA competes with 
KaiA for binding to fold-switched KaiB. The KaiBC complex promotes CikA’s phosphatase activity 
toward RpaA. (Adapted from Cohen and Golden, 2015) 
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1.2.5 Molecular circadian clock in plants 
Arabidopsis thaliana is the model organism used extensively in plant physiology and 
molecular biology research. Most studies of the plant circadian clock have considered A. 
thaliana in which the molecular mechanism underlying the circadian clock is best studied 
(Sanchez and Kay, 2016). In A. thaliana, and plants in general, the circadian clock comprises 
negative feedback loops regulated from transcriptionally to post-translationally, including 
post-transcriptional modification and protein turnover (Harmer, 2009). The molecular 
mechanism of the circadian oscillator can be portrayed based on the timing of the expression 
of morning-, daytime- and evening-phased genes (Figure 1.5). The TTFLs maintain proper 
timing of expression of each gene and their downstream targets throughout the day 
(Greenham and McClung, 2015). 
The first molecular model of a circadian clock in plants was proposed in 2001. The 
TTFLs of A. thaliana consist of three genes: two MYB transcription factors, CIRCADIAN 
CLOCK ASSOCIATED 1 and LATE ELONGATED HYPOCOTYL (CCA1 and LHY, 
respectively), and TIMING OF CAB EXPRESSION 1 (TOC1) also known as PSEUDO-
RESPONSE REGULATOR 1 (PRR1) (Alabadi et al., 2001). CCA1 and LHY mutually 
interact after being expressed in subjective morning and repress TOC1 expression. While 
CCA1 and LHY levels decrease at dusk, TOC1 starts being expressed and negatively regulates 
the transcription of CCA1 and LHY (Huang et al., 2012). An additional loop is formed by 
PRR9, PRR7, and PRR5 (members of the PRR gene family) that show partially redundant 
functions since they are homologs of TOC1 and repress CCA1 and LHY transcription 
(Sanchez and Kay, 2016). It is reported that PRR9 and PRR7 are induced by CCA1 and LHY. 
However, recent studies show that LHY or even TOC1 is a direct repressor of PRR9, PRR7, 
and PRR5 (Adams et al., 2015; Huang et al., 2012). PRR9 is also repressed by the “evening 
complex” (EC). The EC consists of the MYB-like transcription factor LUX ARRHYTHMO 
(LUX, also known as PHYTOCLOCK1), and EARLY FLOWERING 3 (ELF3) and ELF4, 
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two nuclear proteins with unknown biochemical function (Sanchez and Kay, 2016). The EC 
indirectly promotes the expression of CCA1 and LHY in turn repressing the EC components 
(Huang et al., 2012). A third loop was described comprising a morning-expressed group of 
genes, REVEILLE (RVE), homologs of CCA1 and LHY. RVE8 induces the transcription of 
afternoon and evening- phased genes: PRR5, TOC1, LUX, and ELF4. As a consequence, 
RVE8 is repressed by PRR9, PRR7, and PRR5 (Hsu et al., 2013).  
Figure 1.5 The schematic diagram of TTFLs in proposed clock model in Arabidopsis thaliana. The 
circadian time of higher activity level of each component is shown from daytime (left) to night (right). 
REVEILLE/CCA1/LHY family proteins (yellow) activate the expression of PRR5, PRR7 and PRR9; 
pseudo-response regulators (blue) repress the function of REVEILLE/CCA1/LHY family proteins; 
the evening complex components (green) repress PRRs inhibitory activity resulting in the activation 
of REVEILLE/CCA1/LHY family proteins. CCA1/LHY also regulate the expression of the evening 
complex components. RVE8 directly activates multiple evening-phased clock genes and that RVE8 is 
indirectly regulated by TOC1, LUX and CCA1 through their regulation of PRR5, PRR7 and PRR9. 
Only transcriptional regulation is shown. (Adapted from Hsu et al., 2013) 
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1.3 Molecular circadian clock in Neurospora crassa 
1.3.1 Neurospora crassa 
The filamentous fungus Neurospora crassa is one of the most thoroughly studied species. 
N. crassa is used as a model organism because of its simple requirements for culture and its 
haploid asexual life cycle that is convenient for genetic analysis. In the asexual part of the 
cycle, the hyphae from the germination and growth of an asexual spore (conidium) extends 
and branches to a mass of threads. In later development, the cross walls disappear in the 
hyphae so that a colony is a single cell containing numerous haploid nuclei. The nuclei in 
that hyphae can possess different genotypes, comprising a heterokaryon. A colony can 
produce millions of multinucleate macroconidia and uninucleate microconidia from aerial 
hyphae and the asexual cycle is repeated if they keep growing on a suitable medium (Davis, 
2000). 
Neurospora crassa is an exemplary heterothallic species that has two mating types. 
Mating can occur only between strains of opposite mating type (mat A and a, respectively). 
Once the parents come into contact, their cell walls and nuclei start fusing and then fruiting 
bodies called perithecia are formed containing diploid nuclei. Each diploid nucleus 
undergoes meiosis and develops to an ascus. The four products of a single meiosis undergo 
a mitosis that finally produce eight ascospore (sexual spores). The ascospores germinate and 
return to the asexual life cycle (Perkins and Davis, 2000). 
Neurospora crassa is a great model system for studying the mechanism of circadian 
rhythms. The circadian rhythms of Neurospora first were reported in 1959 (Pittendrigh et al., 
1959). However, the spore-formation rhythm is not overt in the wild type. The band mutation 
(also named ras-1bd) is required to observe robust circadian output (Sargent et al., 1966). 
Asexual spore formation is controlled by the circadian clock in Neurospora with a period of 
21.5 h (Dunlap et al., 2007), and this rhythm can be easily assayed on agar medium in race 
tubes, as a pattern of conidial regions called “bands” alternating with fungal mycelium called 
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“interbands” (Li et al., 2011). Since the mycelia need to differentiate and form aerial hyphae 
for conidial production while growing forward, the time between two peaks of bands can be 
calculated based on the distance between peaks and the growth rate (Baker et al., 2012). 
Because the differentiation is static once the growth front has passed and the banding pattern 
can be measured after an experiment is completed, no automated equipment is needed. This 
conidiation rhythm has been the standard assay in labs and all known clock genes were 
identified by observing changes in the conidiation rhythm. Moreover, the genetic and 
biochemical background is well-studied and a relatively large community is supporting the 
research. The genome is fully sequenced (Galagan et al., 2003) and annotated databases are 
available online (FungiDB, http://fungidb.org/fungidb/ and NCBI, https:// 
www.ncbi.nlm.nih.gov/). A near-complete knockout library was built up (Colot et al., 2006) 
and knockout strains are available from the Fungal Genetics Stock Center (FGSC).  
1.3.2 FRQ-WCC oscillator 
Decades ago, Neurospora clock mutants were isolated after mutagenesis of the wild-type 
(bd) strain with either the chemical mutagen N-methyl-N'-nitro-N-nitrosoguanidine (NG) or 
ultraviolet light. Seven mutants with altered circadian period lengths were mapped to a single 
locus called Frq (Frequency) (Feldman and Hoyle, 1973; Gardner and Feldman, 1980), 
located on the right arm of linkage group VII. Since the frq gene was cloned, more 
components have been found to regulate the circadian clock. 
The popular model of the molecular mechanism in Neurospora crassa is a 
transcription/translation feedback loop as well (Figure 1.6). In this loop, the FRQ 
(FREQUENCY), WC-1 and WC-2 (White Collar 1 and 2) proteins are core elements. WC-1 
and WC-2, GATA-family transcription factors with PAS (Per-Arnt-Sim) domains, are 
positive elements that form a heterodimeric complex named WCC (White Collar Complex) 
(Liu et al., 2003). WCC activates the transcription of the frq gene in the late subjective night 
(Baker et al., 2012). FRQ, the negative element, along with its binding partner FRH (FRQ-
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interacting Helicase), inhibits the transcriptional activation of WCC in the nucleus, so 
consequently represses the expression of FRQ. The withdrawal of this repression is 
accomplished by phosphorylated FRQ recruiting the ubiquitin ligase FWD-1 (F-box/WD-40 
repeat-containing protein) causing digestion of FRQ by the proteasome (He et al., 2003). The 
WCC then binds to the promoter of the frq gene again to reactivate the transcription. Since 
WCC also activates a number of clock-controlled genes not limited to the frq gene, this 
rhythmic activation-deactivation of the transcription is considered to drive the 24-hour 
rhythms in output, such as the conidiation rhythm (Guo and Liu, 2010). 
Figure 1.6 The schematic diagram of circadian clock regulation in Neurospora crassa. WC-1 is a 
blue-light photoreceptor and a transcription factor. With the interaction with WC-2, the WCC 
complex activates the transcription of frq. The FRQ homodimer along with the stabilizationer FRH 
are transported into the nucleus and repress the expression of both clock and clock-controlled genes 
activated by WCC. FRQ is being degraded when its expression is inhibited and the abundance of 
FRQ decreases. The transcription of the frq gene restarts after WCC is released from the repression 
and a new cycle initiates again. (Adapted from Liu and Bell-Pedersen, 2006) 
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1.3.3 FRQ-less oscillator 
Although most of the research carried out on the circadian system in Neurospora is 
focused on the FRQ/WCC oscillator, it is known that a conidiation rhythm can be observed 
in the absence of a functional frq gene (Loros and Feldman, 1986; Merrow et al., 1999). Two 
null mutants have been found at the frq locus: frq9, which has a point mutation expressing a 
truncated protein, and frq10, which was constructed by targeted gene deletion (Aronson et al., 
1994). Rhythms appear in frq-null mutants after the first few days of growth on the race tube, 
but the period is more variable than wild type and temperature compensation is defective 
(Aronson et al., 1994; Loros and Feldman, 1986). Calling null mutants of frq, wc-1 and wc-
2 as “conditionally rhythmic” is more accurate than “arrhythmic”, due to rhythmicity that 
can be induced by introducing more mutations or adding chemicals (Aronson et al., 1994; 
Lakin-Thomas, 2006; Lakin-Thomas and Brody, 2000; Lombardi et al., 2007; Merrow et al., 
1999). Molecular rhythms can be seen in frq-null mutants, such as a rhythm in nitrate 
reductase (Christensen et al., 2004) or gene transcription of ccg-16 and levels of WC-1 
protein (de Paula et al., 2006). Rhythmicity in the absence of the FRQ/WCC feedback loop 
must be driven by an oscillator called the FRQ-less oscillator (FLO), but the relationship 
between FRQ/WCC and FRQ-less oscillators has been discussed over the years, and the 
specific mechanism of FLO has not been understood so far (Li et al., 2011). 
  
19 
1.4 The prd-1 gene in Neurospora 
1.4.1 Effects of the prd-1 mutation 
As mentioned above several clock mutants in Neurospora have been identified as alleles 
of the frq gene. But one of the mutants, frq-5, was mapped to a position near the centromere 
on linkage group III (Feldman, 1982). It was renamed prd-1 (period-1) based on its effect on 
lengthening the period of the conidiation rhythm.  
The prd-1 gene appears to play a key role in FRQ-less oscillators. The lipid-deficient 
strain cel sustains a long-period conidiation rhythm in the condition of low temperature or 
supplementation with unsaturated fatty acids when frq and wc -null mutations are introduced 
(Lakin-Thomas and Brody, 2000). The rhythm continues when the prd-1 mutation is 
introduced in cel, but the long-period rhythm is shortened, which suggests the prd-1 mutation 
blocks normal function of FLO (Lakin-Thomas and Brody, 1985).  
The frq10 mutant is rhythmic when geraniol is added to the growth medium, and this 
system was used to assay the influence of prd-1 in FLO. The prd-1 mutants, having a long 
period in the frq+ background, lengthen the period in the frq10 background as well, suggesting 
that prd-1 is an important part of FLO (Lombardi et al., 2007). 
1.4.2 Identification of the prd-1 gene 
Our lab analyzed the rhythmicity of prd-1 in chol-1 frq10 strains using two conditions: 1) 
conidiation rhythms can be seen in chol-1 strains carrying frq and wc null mutants with 
limited choline. 2) Cycles of high temperature pulses can entrain the rhythms in frq and wc 
null mutants (Li and Lakin-Thomas, 2010). Previous work in our lab showed that prd-1 
destroys the free-running FRQ-less rhythm in chol-1 and severely disrupts the heat-entrained 
FRQ-less rhythm in chol-1+ (Li and Lakin-Thomas, 2010). 
Our lab has identified the prd-1 gene as NCU07839, and the product of it, PRD-1, is 
identified as a DEAD (Asp-Glu-Ala-Asp) box RNA helicase (Figure 1.7) (Adhvaryu et al., 
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2016; Emerson et al., 2015). The DEAD-box RNA helicase family is conserved from yeast 
to human, involved in many processes of RNA metabolism, such as transcriptional regulation, 
splicing, nuclear export, ribosome biogenesis, translation and degradation (Linder and 
Jankowsky, 2011). Protein sequence similarity reveals that PRD-1 is homologous to the Dbp-
2 ATP-dependent RNA helicase in yeast and the DDX5 DEAD-box RNA helicase in 
mammals that was found in the complex of proteins constituting the negative arm of the 
mammalian circadian feedback loop (Padmanabhan et al., 2012).  
A single base substitution (G to A) occurs in the third intron of the prd-1 gene (Adhvaryu 
et al., 2016; Emerson et al., 2015). Sequencing of cDNA showed that the mutation affects 
splicing of the pre-mRNA, likely resulting in a premature stop codon (TAA) and a truncated 
PRD-1 protein which loses the C-terminal region, if the third intron cannot be spliced, despite 
the conserved DEAD-box domain and ATPase domain (Adhvaryu et al., 2016). It suggests 
that the C-terminal may be important for mediating the interactions with other proteins, 
especially those that are involved in circadian oscillators. 
A constructed strain that introduced the wild-type prd-1 gene driven by a strong promoter 
ccg-1 inserted into his-3 locus successfully rescued the mutant phenotype (Adhvaryu et al., 
2016; Emerson et al., 2015). This strain shows the normal phenotype which indicates 
sufficient amount of PRD-1 protein can neutralize the effect of the prd-1 mutant. 
Figure 1.7 Organization of the prd-1 gene (A) and protein domains (B). (Adapted from Adhvaryu 
et al., 2016) 
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1.5 Objective of the thesis 
Due to the tight association with the circadian rhythm, the prd-1 gene is hypothesized as 
an important component in the oscillatory mechanism. Despite the identification of the prd-
1 gene encoding a DEAD-box RNA helicase, the function of it especially the one relating to 
the circadian clock is still ambiguous. My project is to study the function of the prd-1 gene 
in Neurospora crassa. 
The prd-1 mutant has a slow-growth phenotype, and the knockout of this gene available 
from the FGSC is only a heterokaryon, suggesting that the prd-1 knockout is lethal. 
Nevertheless, attempts are still necessary to obtain a homokayotic prd-1 knockout strain, 
which is a valuable tool for understanding the function of prd-1.  
Functions possessed by a gene are shown mainly through its expression product, 
therefore, studying the function of the PRD-1 protein will help us to expound the molecular 
mechanism of FLO in Neurospora crassa. Due to the unavailability of PRD-1 antibody, 
constructing a strain expressing FLAG-tagged PRD-1 is the prerequisite of experiments such 
as the examination of the rhythmicity of PRD-1 and Co-IP to find binding partners.  
The phenotype of the prd-1 mutant is clock-relevant, but we know little about the prd-1 
gene. If the prd-1 gene is clock-controlled, the PRD-1 protein and its mRNA should be 
rhythmic. Recently, it was published by another laboratory that the expression of PRD-1 and 
its mRNA is arrhythmic in wild type and light cannot induce changes of PRD-1 level 
(Emerson et al., 2015). In addition, it was proposed that different metabolic conditions may 
affect the expression of PRD-1, but abundance of PRD-1 was not assayed under different 
conditions. The research also did not test the expression of PRD-1 in frq-null strains, which 
is important to test if PRD-1 has a function associated with the FLO. I hypothesize that the 
expression of the prd-1 gene at mRNA or protein level may be different under different 
growth conditions or under the frqKO background.  
Although research showed that PRD-1 has no strong interactions with the positive and 
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negative elements in the FRQ-WCC oscillator (Emerson et al., 2015), whether the PRD-1 
protein could bind to other proteins is still unclear. I presume that PRD-1 could interact with 
other proteins that have not been discovered to be correlated to the circadian clock yet. 
Whether the binding partners could affect the circadian rhythm needs deeper research. 
Immunoprecipitation followed by Mass Spectrometry to identify proteins interacting with 
PRD-1 should provide information about the function of PRD-1. 
Last but not least, since the mutation causes the alteration of the sequence at C-terminal 
end, whether the C-terminus of PRD-1 is required for its function in the circadian clock needs 
to be determined. My hypothesis is that the function of the prd-1 gene would be dramatically 
altered or abolished if the C-terminus is deleted. The phenotype of the deleted strain could 
provide valuable clues about the function of the C-terminus of PRD-1.  
 
  
23 
Chapter 2  Essentiality of the prd-1 gene and its C-terminus 
2.1 Introduction 
The prd-1 gene has been identified as NCU07839 and abnormally spliced mRNA of prd-
1 has been discovered by our lab. The mutated prd-1 gene resulted in the change of the 
phenotype. My presumption was that the prd-1 gene is a critical component in the circadian 
clock and the circadian rhythm is abolished without the prd-1 gene. Hence, obtaining an 
NCU07839KO strain will be our first priority to understand its function.  
However, in Neurospora even though it is haploid, one spore may possess more than one 
nuclei (Maheshwari, 1999). It is called a heterokaryon if a strain contains nuclei with different 
genotypes. To completely delete this gene in the cells, every copy of NCU07839 should be 
knocked out. In 2006, a consortium of labs constructed a library attempting to knock out 
every gene by a high through-put gene replacement method (Colot et al., 2006). In this library, 
we found that only a heterokaryotic NCU07839KO strain is available, whose spores contain 
both wild type and knock-out nuclei. This implies that the deletion of the prd-1 gene results 
in the death of the cells. To ensure the essentiality of prd-1, we obtained this heterokaryon 
from FGSC and tried to isolate the NCU07839KO nucleus. 
Neurospora crassa produces relatively small numbers of uninucleate microconidia and 
very large numbers of multinucleate macroconidia in asexual vegetative life cycle. The 
environmental factors such as high humidity, low nutrition concentration, temperature and 
supplementary chemicals favor the formation of microconidia (Maheshwari, 1999). In 
practice, the microconidia preparation has been applied to obtain homokaryotic 
transformants for many years. Therefore, I planned to harvest microconidia to purify the prd-
1KO heterokaryon. 
The point mutation in the prd-1 mutant causes alternative splicing at the 3’end of the 
mRNA, and the incorrectly spliced mRNAs could be translated to truncated proteins or 
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proteins with incorrect amino acid sequences at the C-terminus (Adhvaryu et al., 2016). The 
structural metamorphosis that may be caused by the mutated amino acid sequence may result 
in disfunction or a neomorph. I hypothesized that although the helicase domain of PRD-1 
protein may be essential for survival, it may be the C-terminus of PRD-1 that makes a 
difference to the circadian rhythm. To verify this assumption, I planned to construct a strain 
that can only express the truncated PRD-1 protein whose C-terminus has been deleted. 
Therefore, I decided to do a gene replacement to knock a C-terminus deleted prd-1-FLAG 
cassette (prd-1ΔC-flag) into the genome and compare the phenotype with wildtype and the 
prd-1 mutant. In case the C-terminal deletion of prd-1 is lethal, I also planned to knock in a 
wild type prd-1 with FLAG as the control. 
Two main pathways have been discovered in DNA repair that depend on DNA sequence 
homology: homologous recombination (HR) and nonhomologous end-joining (NHEJ). 
Homologous recombination is the most commonly applied and efficient method of gene 
replacement. HR occurs rarely in the wild-type Neurospora crassa. In 2004, the mutants 
named Δmus-51 and Δmus-52 were engineered to reduce the nonhomologous end-joining 
(Ninomiya et al., 2004). Vegetative growth, conidiation, and ascospore production were 
normal in homozygous crosses. The recombination of exogenous DNA into the genome is 
very high in those two strains, compared to 10 to 30% for the wild type (Ninomiya et al., 
2004). After transformation, the mus-mutation needs to be removed to eliminate unknown 
effects. The prd-1 gene and mus-52 gene are localized in the same linkage group which 
cannot be efficiently segregated by crosses. Therefore, I used Δmus-51 for the knock-in work. 
The cutting-edge CRISPR/Cas9 technology has been proved to be effective for efficient 
gene editing in Neurospora crassa as well as other various organisms (DiCarlo et al., 2013; 
Fuller et al., 2015; Matsu-Ura et al., 2015; Tsarmpopoulos et al., 2016). Three plasmids with 
Cas9, guide RNA (gRNA) expression cassette, and knock-in cassette are transformed into 
the cell simultaneously. The Cas9 endonuclease can create a double-strand break guided by 
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the RNA targeting the desired region. The DNA repair pathways then are triggered and HR 
will occur with the presence of the knock-in DNA cassette containing homologous genomic 
sequence. The efficiency of this method has been demonstrated to be competitive to the 
method above which is accomplished by Δmus-51/52 strains (Matsu-Ura et al., 2015). The 
advantage of the CRISPR gene editing method is that the transformation can be achieved in 
any recipient and the strain can be immediately used after transformation without the 
requirement of crossing. Hence, I also planned to introduce this method for the knock-in 
project.  
The knock-in DNA cassette consists of at least four units: upstream homologous region 
(5’ flank), designed sequence of replacement, selection marker and downstream homologous 
region (3’ flank). To obtain a plasmid vector carrying this cassette, at least 5 restriction 
enzymes are required for the construction. It is reported that assembly PCR (overlapping 
PCR) could produce DNA fragments with complex content from hundreds of base pairs to 
20 kb long (Bryksin and Matsumura, 2010; Shevchuk et al., 2004; Xiong et al., 2004; Yang 
et al., 2012). I planned to prepare the DNA segments in this way. 
For the C-terminal deletion knock-in cassette, the upstream homologous region was 
designed as 1500 bp ending at the site of the mutation of the prd-1 gene. For the wild-type 
knock-in cassette, the upstream homologous region was designed as 1500 bp sequence before 
the end of the coding sequence. 10xGly, 3xFLAG and two stop codons were added thereafter 
to comprise the open reading frame. Antisense hygromycin resistance gene (hph) was 
inserted as the selection marker. The downstream homologous region was 1500 bp 
downstream of the prd-1 gene (Figure 7.1a). The whole knock-in DNA cassette was 
combined with a vector not homologous with the genome of Neurospora.  
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2.2 Materials and Methods 
2.2.1 Strains  
All the strains from lab stock will be identified using their stock number and simplified 
name. The characteristics of strains are displayed in parenthesis. The entire genotype of each 
strain is specified in Appendix A. #26 (bd csp-1 chol-1) was considered as wild type and a 
recipient of transformation. #567 (Δmus-51, his-3) was also a recipient of transformation. 
The #518 strain to produce microconidia for fluorescence microscopy was obtained from the 
lab stock, a heterokaryon expressing RFP-VAM-3 and NCU05950-GFP. The prd-1KO 
heterokaryotic strain was obtained from FGSC (FGSC#15506).  
2.2.2 Microconidia purification 
Methods were modified from the article (Ebbole, D., and M.S. Sachs, 1990). IAA-SC 
medium [0.1 X SC medium (Appendix B), 0.5% sucrose, 2% agar, 1 mM Na-iodoacetate] 
was added into slanted test tubes. Macroconidia were inoculated onto the medium and 
incubated at room temperature for 7-12 days. Microconidia were washed off with water and 
filtered through Millipore Durapore Millex 5 µm filters (Millipore). The numbers of 
microconidia were counted using hemocytometer. The microconidia suspension was mixed 
with sorbose plating medium [0.1% fructose, 0.1 % glucose, 2 % sorbose, 1X Vogel’s salt 
(Appendix B), 2% Agar,] and poured into 100mm Petri plates. Colonies grown on sorbose 
plates were transferred to 2% glucose Vogel’s agar medium for further tests. 200 µM 
hygromycin B was added into each medium when necessary. 
To harvest the microconidia of the transformants, 20ml IAA-SC medium (0.1 X SC 
medium, 0.5% sucrose, 2% agar, 1 mM Na-iodoacetate) was poured in 100mm Petri plates. 
A sterile circular cellophane piece which is slightly larger than the plate was laid onto the 
medium. Spores were inoculated in the hole pierced at the centre of the cellophane. Plates 
were incubated upside down in a sealed box with humid atmosphere at room temperature for 
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7-12 days. All the mycelia and spores outside of agar were cleared up and the cellophane was 
peeled off before substituting a new lid. The plates were incubated at room temperature for 
another day and the microconidia were washed off from the agar surface with 2ml water. 
Diluted microconidia suspension was mixed with sorbose plating medium and poured into 
100mm Petri dishes for colony growing.  
2.2.3 Race tube assay 
The growth medium was Vogel’s minimal medium (Appendix B) with 0.5% maltose, 
0.01% L-Arginine and 2% agar. Choline was added at 100 μM when indicated. Both medium 
and 30 cm glass tubes with cotton plugs (race tubes) were autoclaved at 121°C for 30 minutes. 
6 mL medium was transferred into each race tube before solidification. Spores were 
inoculated on one side of the medium. The race tubes were placed in constant light (LL) at 
30°C for one day and then transferred to constant darkness (DD) at 22°C. The growth front 
was marked every day under red safelight and the growth rate and period were calculated as 
previously described (Lakin-Thomas, 1998). 
2.2.4 Spore PCR  
Spore PCR was carried out using Terra™ PCR Direct Polymerase (Takara Bio Inc.). 
PCR conditions were set as recommended by the manufacturer.  
To test the genotype of each microconidium from the prd-1KO strain, primers targeting 
the knockout region (rc 5r prd-1KO and rc 3f prd-1KO) were used. The primers (NCU07839-
2661-F and FLAG-R) were used to check the deletion region and FLAG. The primers 
(Primer-F11 and DownstreamNCU07839-R1) were used to assay whether the knock-in 
strains were homokaryons. Annealing temperature and extension duration varied with pairs 
of primers. The names of primers used for amplification will be annotated and the sequences 
of primers are listed in Appendix C. 
2.2.5 DNA agarose gel electrophoresis 
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Agarose was dissolved in TAE buffer (40mM Tris, 20mM acetic acid, and 1mM EDTA) 
by microwaving. The agarose gel was mixed with 0.005% RedSafe™ Nucleic Acid Staining 
Solution (iNtRON Biotechnology) and poured into the cast with combs. DNA was loaded 
into the wells and electrophoresis was run in TAE buffer.  
2.2.6 Regular PCR 
DNA amplified from genomic DNA of Neurospora or from plasmid DNA was obtained 
by using Q5® High-Fidelity DNA Polymerase (NEB). PCR conditions were set as 
recommended by the manufacturer. Annealing temperature and extension duration varied 
with pairs of primers. The names of primers used for amplification will be annotated and the 
sequences of primers are listed in Appendix C. 
2.2.7 Assembly PCR 
Primers were designed to introduce overlaps to the ends of each DNA fragment. The 
overlaps of DNA fragments were about 50 bp long and shared similar Tm. After amplifying 
DNA fragments with overlaps by regular PCR, 50ng purified candidates as the templates 
were added into PCR reaction systems containing 0.5µM of the outer primers. Other 
components in the PCR reaction systems were added following the protocol of Q5® High-
Fidelity DNA Polymerase. PCR conditions were set as recommended by the manufacturer. 
Annealing temperature was set as 60°C which was the designed Tm for the primers. The 
extension duration varied with the length of expected DNA fragments. Agarose gel 
electrophoresis was conducted to analyze the PCR products. 
2.2.8 Techniques related to molecular cloning 
PCR clean-up and DNA gel purification were done with Gel/PCR DNA Fragments Kit 
(Geneaid). Restriction enzyme digestion, ligation and bacteria (NEB® 10-beta Competent E. 
coli) transformation were executed following the protocols from the manufacturer. High-
Speed Plasmid Mini Kit and Midiprep Plasmid DNA Kit (Geneaid) were utilized for the 
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plasmid extraction. Recombinant plasmids were sent to Sanger DNA sequencing service (Bio 
Basic Inc.) for sequencing and the results were aligned with the N. crassa database (FungiDB, 
http://fungidb.org/fungidb) in A Plasmid Editor (ApE, by M. Wayne Davis). 
2.2.9 Transformation of Neurospora 
The spores of transformation recipients were inoculated on 3ml Vogel’s agar medium 
with 2% glucose in the slanted tubes and incubated for one week at room temperature. The 
contents in the slanted test tubes were transferred on 100ml Vogel’s agar medium with 2% 
glucose in 1L flasks. 0.5mg/ml histidine was added in the media if necessary. The tissue in 
the flasks was scraped off and transferred into 50ml conical tubes. The spores were washed 
off with water by vortex. The spore suspension was filtered through four-layer cheesecloth 
and spin down at 3,000g at room temperature. The pellet was washed with water and spin 
down three more times. The pellet of spores was resuspended in an equal volume of 1M 
sorbitol. The resuspension of spores was stored at -80°C. 
About 1 x 108 conidia was mixed with 10µg linearized plasmid DNA in 50 µl 1M sorbitol 
and incubated on ice for at least 15 min. The mixture was transferred into ice-cooled 2 mm 
electroporation cuvette and electroporated with the following parameters: voltage gradient: 
7.5 kV/cm (1.5 kV in a 0.2 cm cuvette), capacitance: 25 µF, resistance: 600 ohms, using Gene 
Pulser® II Electroporation System (Bio-Rad). The transformed spores were resuspended with 
1ml recovery medium (1x Vogel’s salts, 1M sorbitol, 2% sorbose, 0.5% fructose, 0.5% 
glucose) immediately after the electroporation and incubated at room temperature with gentle 
rotation for 1hour. Transformed spores then were mixed with sorbose plating medium 
containing 1M sorbitol and poured into 100mm Petri dishes for colony growing. Other 
supplements (choline) were added into all types of medium when necessary. 
2.2.10 Crossing  
The female (mat A) was grown on 3ml synthetic crossing (SC) agar medium with 
supplements needed (choline or histidine). The male (mat a) was grown on Vogel’s agar 
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medium with 2% glucose and supplements needed. After 5-7 days, the spores of the male 
were spread on the medium of the female and incubated at room temperature for 3-4 weeks. 
Individual ascospores were picked or separated into the Vogel’s agar medium with 2% 
glucose and supplements needed for further tests.  
Genotypes of multiple mutant strains were identified by various criteria: rasbd by slower 
growth and banding phenotype, csp-1 by failure of conidial separation, chol-1 by slow growth 
without choline supplementation, frq10 by arrhythmic conidiation on high choline and 
presence of banding rhythms on zero choline in chol-1 strains, and gene deletions by 
hygromycin resistance or by spore PCR with gene-specific primers to confirm gene 
replacement (Adhvaryu et al., 2016). 
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2.3 Results 
A knockout strain would be a very useful tool for studying the function of PRD-1. 
However, only a heterokaryon knockout strain of the prd-1 gene is available from the FGSC, 
suggesting that prd-1 is an essential gene. After we received that knockout strain from FGSC, 
we tried to obtain a homokaryon strain by microspore purification.  
2.3.1 Microconidia purification is effective to select homokaryons 
The effectiveness of microconidia purification was my first concern. I tested the method 
by using a heterokaryon from our lab that has two types of nuclei: one carries RFP and the 
other carries GFP (Figure 2.1). The nuclei with GFP are a knockout of NCU05950 which is 
replaced by the hph (hygromycin resistant) gene. The nuclei with RFP do not have the hph 
gene. After harvesting microconidia, I plated 200 on the plates with hygromycin and 200 
spores on plates without hygromycin. Under a fluorescence microscope I found that 139 
colonies only expressing GFP could grow on the hygromycin plates, even though 3 
heterokaryons expressing both RFP and GFP were found. On the plates without hygromycin, 
I found 76 colonies that only express GFP, 27 colonies that only express RFP and 28 colonies 
that are suspicious of being heterokaryons (Figure 2.1). These results demonstrate that 
microconidia purification can successfully generate colonies with a single type of nuclei.  
2.3.2 The prd-1 gene is essential for Neurospora crassa 
I next spread microconidia that were harvested from the prd-1 knockout heterokaryon 
strain. Based on the information from FGSC, the hph gene was introduced into the genome 
to knock out the prd-1 gene. As expected, only 2 colonies grew on the hygromycin plates and 
hundreds of colonies grew on the plates without hygromycin (Figure 2.1). To test their 
genotype, I ran spore PCR using the primers from both flanks of the transcript of the prd-1 
gene (refer to 2.2.4). The DNA gel showed that the heterokaryotic prd-1 knockout strain 
obtained from FGSC has two sorts of nuclei and colonies from microconidia have only one 
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type of nuclei. For the colonies selected by hygromycin, a very faint band of wild-type prd-
1 gene can be observed, indicating that they may still be heterokaryons with only a few wild-
type nuclei present under the drug selective pressure (Figure 2.2). To further check whether 
they are homokaryons, I grew them on race tubes without hygromycin and did spore PCR of 
spores from both ends of the tubes. Spore PCR showed that the number of wild-type nuclei 
increased and both colonies are heterokaryons (Figure 2.3). The growth rates of those two 
colonies were same as wild-type on the race tubes.  
 
 
Figure 2.1 Schematic results of sorbose plates with/without hygromycin selection. The single nucleus 
is isolated from heterokaryons by microconidia purification. Normally one microconidium forms one 
colony on the sorbose plate but two microconidia may form one colony when they are too close.    
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Figure 2.2 Result of prd-1KO spore PCR after microconidia purification. In the knockout strain, prd-
1 is replaced by hph (hygromycin resistant gene). No.1-24 are colonies grown on the sorbose plates 
without hygromycin B. Hygro+ #1, 2 are colonies selected by hygromycin B. Target bands should be 
3kb for prd-1 gene and 1.5kb for hph gene. 
Figure 2.3 Result of spore PCR from both ends of race tube. #1, 2 are colonies selected by 
hygromycin B after microspore purification. A represents spores that are from the beginning of race 
tube and B represents spores from the end of race tube. W means wild-type strain (#259 Oak Ridge). 
M represents 1kb ladder (GeneDirex). 
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2.3.3 The failure to construct knock-in DNA cassette by assembly PCR 
I planned to amplify the DNA cassette by assembly PCR and then ligate it into a blunt-
end vector. I first attempted to assemble the four units in one reaction (Figure 2.4a). I also 
failed to assemble DNA fragments two by two. The assembly PCR did not work with these 
long DNA fragments when I used a gradient of annealing temperature. Then I designed 
primers to dissect every large piece into ~500bp small segments, and then assembled them 
all at once or two by two (Figure 2.4b). Frustratingly, I could ligate two 500bp DNA by 
overlapping PCR, but I failed to use 1kb segments to ligate anymore (Figure 2.4 c, d). In 
short, assembly PCR could not ligate large fragments (>1kb) even though the PCR conditions 
were optimized.  
2.3.4 The construction of knock-in DNA cassette and guide RNA 
expression plasmid by restriction endonucleases 
I turned to design the construction with restriction enzymes due to the failure of assembly 
PCR. Considering the low efficiency of ligating five pieces at once, I planned to build two 
subclones first and then ligate two DNA fragments together which are amplified from the 
subclones (Figure 2.5). The subclone 1 carried the 5’flank and the sequence of replacement 
(pBM61-ccg-prd-1ΔC-FLAG; pBM61-ccg-prd-1-FLAG was made in Chapter 3), and 
subclone 2 contains the selection marker and the 3’flank (pJET-hph-3’flank). The C-terminus 
deleted prd-1 gene as 5’flank was amplified by PCR. The digested PCR product was ligated 
into the plasmid (pBM61-ccg-prd-1-FLAG) from lab stock. The subclone 2 was made by 
inserting hph and 3’flank into the backbone of a plasmid (pJET-native-prd-1) from lab stock. 
The hph gene is amplified from pCSN44 which was obtained from FGSC. For the final 
construct (pJET-prd-1ΔC-FLAG-KI, pJET-prd-1-FLAG-KI), SbfI and XbaI were introduced 
to the ends of the 5’flank+Gly-FLAG and the subclone 2. The digested purified DNA pieces 
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were ligated accordingly and transformed into bacteria. The recombinants were confirmed 
by the size via digestion (Figure 2.6 a, b, c, d) and by the sequencing results.  
Plasmids expressing Cas9 and gRNA were bought from Addgene. The gRNA sequence 
needed to be substituted by a sequence in prd-1. 20bp sequence was chosen as guide RNA 
which is in the 3’ UTR close to the stop codon in the prd-1 gene and it showed high specificity 
compared to the whole genome. The substitution sequence was synthesized by Bio Basic Inc. 
and inserted into the gRNA expression plasmid by NheI and KpnI. The recombinants were 
confirmed by the size via digestion (Figure 2.6e) and by the sequencing results. 
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Figure 2.4 The construction of knock-in DNA cassette by assembly PCR. a) The design of knock-in 
cassette. Primers for amplifying each fragment: NCU07839-1662-F & NCU07839-3161+Gly-R, 
NCU07839-3161+Gly-F & Flag+TtrpC-R, Flag+TtrpC-F & PtrpC+downstreamNCU07839-R, 
PtrpC+downstreamNCU07839-F & Downstream NCU07839-R, from left to right, respectively. b) 
The design of small fragments for assembly PCR. Primers for amplifying each fragment from left to 
right are listed in the Table 7.1. c) Assembly PCR results of small fragment assembly (<500bp). M: 
100bp DNA ladder d). Assembly PCR of large fragment assembly (>500bp). M: 1kb DNA ladder. 
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Table 2.1 Primers used for the amplification of fragments in Figure 2.4b 
DNA fragment Forward Primer Reverse Primer 
5’flank a NCU07839-1600-F NCU07839-2259-R 
5’flank b NCU07839-2181-F NCU07839-2733-R 
5’flank c NCU07839-2661-F NCU07839-3161+Gly-R 
10xGly-3xFLAG NCU07839-3161+Gly-F Flag+T trpC-R 
hph a Flag+T trpC-F T trpC-R1 
hph b T trpC- F1 Hph-R1 
hph c Hph-F1 Hph-R2 
hph d Hph-F2 Hph-R3 
hph e Hph-F3 PtrpC+downstreamNCU07839-R 
3’flank a PtrpC+downstreamNCU07839-F Downstream NCU07839-R1 
3’flank b Downstream NCU07839-F1 Downstream NCU07839-R2 
3’flank c Downstream NCU07839-F2 Downstream NCU07839-R3 
 
Figure. 2.5 Schematic graph of the construction of plasmids carrying knock-in cassette.  
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Figure 2.6 DNA gel pictures of digested plasmids. Expected bands are annotated beside each picture.  
a) pBM61-ccg-prd-1ΔC-FLAG. b) pJET-hph-3’flank. c). pJET- prd-1ΔC-FLAG-KI. d) pJET- prd-1-
FLAG-KI. e) gRNA expression plasmid. 
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2.3.5 The construction of knock-in transformants 
2.3.5.1 Knock-in of Δmus-51 strain 
15µg of plasmid carrying the knock-in DNA cassette was linearized and electroporated 
into the Δmus-51 strain (#567). Colonies grown on sorbose plating medium with hygromycin 
were transferred to individual test tubes with 1ml 2% glucose Vogel’s agar medium. Spore 
PCR was done to check the deleted region with primers (NCU07839-2661-F and FLAG-R). 
The gel picture showed that the designed sequence was successfully integrated onto the 
genome (Figure 2.7a).  
2.3.5.2 Knock-in of wild type strain by CRISPR gene editing 
Once all the plasmids were obtained, three plasmids were co-transformed into the 
macrospores of a wild type (#26) at the same time. One plasmid expresses the guide RNA, 
one expresses the Cas9 protein to cleave the prd-1 gene, and the knock-in plasmid would be 
integrated into the genome via the HR pathway. Colonies grown on the sorbose medium with 
hygromycin were transferred to individual test tubes with 1ml 2% glucose Vogel’s agar 
medium. Spore PCRs were done to check the deleted region and to check whether the 
colonies were heterokaryons (Primer-F11 and DownstreamNCU07839-R1). The gel picture 
showed that the designed sequence was successfully integrated onto the genome and that all 
the colonies were heterokaryons (Figure 2.7b).  
2.3.6 The essentiality of C-terminus of the prd-1 gene 
To observe the phenotype of the prd-1ΔC-flag strain, the mutation Δmus-51 needed to 
be eliminated to minimize the unknown effects and the untransformed nuclei carrying the 
wild type prd-1 gene needed to be removed to prevent the rescue of phenotype. Meanwhile, 
the bd mutation needed to be introduced to show overt circadian rhythms. Therefore, I 
crossed the transformants with #26 to select the homokaryotic bd chol-1 prd-1ΔC-flag strain.  
Progenies were isolated on sorbose plating medium and the numbers of colonies on both 
media with/without hygromycin selection were counted (Figure 2.8a). Genetic analysis 
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showed the possible proportion of the ascospores that could grow on the media when at least 
one out of 2 or 3 nuclei was transformed in each conidium. The results of the control (prd-
1+-flag knock-in) corresponded to the expectation of ‘viable’. 
However, the results of the C-terminal deletion strains met the expectation of ‘lethal’. 
Spore PCR was used to examine the colonies grown on the hygromycin medium. Consistent 
with the expectation, most of the progenies from the control transformation were 
homokaryons; all the progenies from the C-terminus deleted prd-1 strains were 
heterokaryons suggesting that the spores could not survive with only the truncated prd-1 gene 
(Figure 2.8b).  
The homokaryotic prd-1+-flag knock-in strains were grown on race tubes and the 
phenotypes were close to the wild type (Figure 2.9). These data validated my design of the 
knock-in cassette and the methods utilized.  
For the transformants obtained using CRISPR gene editing, they underwent both 
microconidia purification and a cross to collect homokaryons. I failed to select homokaryons 
of either the control or deletion strains from microconidia by PCR. The numbers of colonies 
that grew on the media with/without hygromycin selection were corresponding to our 
theoretical genetic analysis and the results confirmed that the prd-1+-flag knock-in strains 
were viable and the prd-1ΔC-flag knock-in is lethal (Figure 2.10a). However, a homokaryon 
of the control transformants could not be found by spore PCR regardless that the C-terminus 
deleted prd-1 strains were all heterokaryons (Figure 2.10b). These results demonstrated that 
the method of CRISPR gene editing needed to be optimized.  
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Figure 2.7 Spore PCR of the knock-in transformants. Expected bands are labeled beside each picture. 
a) The DNA was knocked into #567. M: 100bp ladder. b) The DNA was knocked into #26 triggered 
by CRISPR gene editing. The deletion region and the FLAG tag check (upper), deleted bands is 600bp; 
The heterokaryon check (lower), the replaced genomic sequence should be about 3kb. M: DNA ladder. 
P: pJET- prd-1-FLAG-KI. 
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Figure 2.8 The purification of homokaryotic knock-in transformants of #567 (Δmus-51). a) The 
diagram of the cross to #26. The proportions of the ascospores that could germinate on each medium 
in theory are shown. The numbers of colonies on the plates are shown. *: the colonies were identified 
as heterokaryons. b) Spore PCR to check the heterokaryons. Expected bands are labeled. Transformed 
prd-1+: 3.1kb; Untransformed prd-1+: 1.5kb; Transformed prd-1ΔC: 2.7kb. M: 1kb ladder. 
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Figure 2.9 The race tubes of selected prd-1+-flag homokaryons. The strains were incubated on 
Vogel’s agar medium with 0.5% maltose, 0.17% L-arginine and 100μM choline (+) or without choline 
(-) at 22°C, DD.  
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Figure 2.10 The purification of homokaryotic knock-in transformants of #26 triggered by CRISPR 
gene editing. a) The diagram of the cross to #149 (bd frq10 his-3, mat A). The proportions of the 
ascospores that could germinate on each medium in theory are shown. The numbers of colonies on 
the plates are shown. b) Spore PCR to check the heterokaryons. Expected bands are labeled. 
Transformed prd-1+: 3.1kb; Untransformed prd-1+: 1.5kb; Transformed prd-1ΔC: 2.7kb. M: 1kb 
ladder. 
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2.4 Conclusion 
The effective separation of GFP/RFP expressing nuclei as the control illustrated the 
validity of microconidia purification. Although heterokaryons were found on the plates, it is 
possibly due to some macrospores getting through the filter or incidences that two 
microconidia may merge to one colony by chance. 
The attempt to isolate prd-1KO homokaryons failed, showing that replacing prd-1 with 
hph causes the death of Neurospora. On the hygromycin plates, since the growth of 
microconidia is inhibited rather than killed, the wild-type microconidia will germinate. If a 
prd-1KO microconidium is close enough to the wild-type one, they will merge and share the 
functional prd-1 and hph gene. This heterokaryon subsequently is able to grow on the 
hygromycin plates. The heterokaryotic genotype of the colonies from hygromycin plates 
confirmed it. Surprisingly, from the results of spore PCR, in selected heterokaryons, wild-
type nuclei compose an extremely small proportion of total nuclei, which still is enough to 
sustain the viability of the microconidia. In conclusion, prd-1 is an essential gene of 
Neurospora crassa. A small amount of PRD-1 protein may be sufficient for its function, or 
perhaps the expression of prd-1 is highly effective to produce sufficient amount of PRD-1 
from a few copies of the gene.  
In this chapter, the designed DNA sequence was knocked into the genome successfully 
and heterokaryotic transformants were viable. Once I tried to isolate homokaryons, the C-
terminal deletion of the prd-1 gene caused inviability but the wild-type prd-1 knock-in strains 
were acquired through crosses. As a conclusion, the C-terminus of the PRD-1 protein is 
indispensable for its normal function, but whether the normal function is associated with the 
circadian clock requires deeper investigation. 
I also attempted to introduce assembly PCR and CRISPR gene editing methods to my 
experimental work to construct the knock-in DNA cassette and knock-in strains respectively, 
along with conventional methods that were applied to Neurospora crassa for many years. 
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The canonical methods worked perfectly whereas the new methods need further 
troubleshooting and optimization. The assembly PCR cannot give products when long DNA 
pieces were the unit of assembly. The CRISPR gene editing successfully triggered the DNA 
repairing pathway and the knock-in cassette was integrated into the genome. However, the 
failure to purify the prd-1+-flag knock-in strains implies that some off-target effects occurred 
during the DNA damaging and DNA repairing processes which might generate some lethal 
mutation or multiple copies of wild-type prd-1 gene in one nucleus since the NHEJ pathway 
is still functional in WT. 
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Chapter 3  Rhythmicity of the prd-1 gene 
3.1 Introduction 
The prd-1 gene has been considered as a component in the FLO to regulate the circadian 
rhythm based on the phenotype of the mutant. Typically, the key proteins such as FRQ, PER-
1 and CRY controlling circadian clocks have a rhythmic expression level in a constant 
environment (Baker et al., 2012; Takahashi, 2017; Tataroglu and Emery, 2015). Conversely, 
if the expression level of PRD-1 is rhythmic, it is more probable that PRD-1 plays a direct 
role in regulating the circadian clock. To examine the expression level of a protein, a common 
method is by Western blotting with proteins extracted at different time points over two or 
three days (Baker et al., 2012; Cheng et al., 2005). A reliable antibody is required for the 
immunodetection. Since no antibody of PRD-1 is available, it is more practicable to tag the 
protein with an epitope (FLAG/GFP) for Western Blotting.  
Moreover, studying the interactions between PRD-1 and other proteins will make an 
important contribution to understanding the function of PRD-1. The known function of the 
binding partners could give us clear guidance on discovering the function of PRD-1. Co-
immunoprecipitation is a standard way to purify proteins that interact with proteins of interest 
(Cheng et al., 2005). Mass spectrometry will identify the pulled-down proteins. The Co-
IP/MS experiment needs a solid binding between the protein complex and antibody on the 
beads. M2 Anti-FLAG Affinity Gel has been successfully applied for IP in many labs (Honda 
and Selker, 2009; Yang et al., 2006). Hence, constructing a strain expressing FLAG-tagged 
PRD-1 protein is very useful for studying the PRD-1 protein. 
PRD-1 has been shown to be a nuclear protein (Adhvaryu et al., 2016). The N-terminus 
of PRD-1 is considered to include a nuclear localization signal (NLS) by DELTA-BLAST 
(Domain Enhanced Lookup Time Accelerated BLAST) in the NCBI website. Tagging the 
FLAG at N-terminus may block the transportation of the PRD-1 protein into the nuclei. The 
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C-terminus of PRD-1 may have a function since mutation of the C-terminus of PRD-1 results 
in the alteration of phenotype. Thus, a relatively smaller tag would probably cause less effect 
on the normal function of the protein. Tagging the FLAG at the C-terminus is extensively 
applied in many publications. Based on my assessment of the risks of linking the tag to either 
terminus, I decided to attach FLAG to the C-terminus of PRD-1.  
Since prd-1 is an essential gene and a low amount of the prd-1 gene is sufficient for its 
function (Chapter 2), it is difficult to know whether the prd-1 gene has a strong promoter. To 
get clear results for Co-IP, higher expression is preferred. The common strong promoter we 
use in our lab is the ccg-1 promoter, which is demonstrated to be effective by previous work. 
The native promoter of the prd-1 gene is also required for determining whether the prd-1 
gene is normally rhythmically expressed. Therefore, I planned to construct two strains 
expressing PRD-1-FLAG driven by either the ccg-1 promoter or the native promoter (ccg-
prd-1-flag and native-prd-1-flag).  
Inserting the expression cassette at the his-3 locus by the HR (homologous 
recombination) is the routine transformation used in Neurospora to express FLAG-tagged 
proteins (Emerson et al., 2015; Honda and Selker, 2009). The recipient carries a mutated his-
3 gene in which a point mutation was found in the 3’ coding sequence. The his-3 mutant 
requires exogenous histidine for growth. The expression cassette is comprised by three 
regions: the 5’flank, the insert sequence and the 3’flank. The 5’flank of the cassette is a wild-
type his-3 gene with the 5’ sequence deleted, and the 3’flank of the cassette is homologous 
to the downstream 3’flank of the his-3 gene. During the HR, the his-3 gene between the 5’ 
and 3’ flank will be replaced by the expression cassette and the function of the his-3 gene is 
repaired. Only the his-3- spores whose his-3 gene is successfully repaired with exogenous 
plasmid DNA can grow without additional histidine. Owing to the lethal effect of prd-1KO, I 
can only transform an expression cassette into the his-3 locus of the strains with prd-1+ or 
prd-1 mutant background. As a result, more than one copy of prd-1 is functioning, which 
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means that the phenotype of transformants may not be exactly the same as the wild type 
because of the possible influence caused by higher dosage of PRD-1. Therefore, I will choose 
transformants with the phenotype close to the wild type for subsequent experiments.  
Rhythmic behavior is a reflection of the rhythmicity of molecular machinery. Since the 
prd-1 mutant has an altered phenotype, it is presumed that PRD-1 may regulate the circadian 
clock. Many proteins that are believed to control the circadian clock are rhythmically 
expressed in both protein level and mRNA level (Dunlap, 1999; Panda et al., 2002). Thus, 
the rhythmicity of the expression of the prd-1 gene may give some clues about whether it is 
directly involved in the molecular clock. Rhythmic expression is an important trait of the 
clock genes; however, a significant portion of total transcripts are also expressed circadian 
rhythmically (Reddy et al., 2006). The prd-1 gene may also be a clock-controlled gene which 
affects the output of the rhythms that are downstream of the molecular clock if the expression 
of prd-1 is rhythmic. In either way understanding the rhythmicity of the expression of prd-1 
is very helpful to narrow down the range of its possible functions. 
In 2015, Emerson et al published their work on examining the expression of prd-1 
(Emerson et al., 2015). They traced the luciferase activity which is driven by the promoter of 
prd-1 and concluded that the promoter of prd-1 cannot produce a rhythmic expression of 
luciferase. They also collected samples every four hours over two days and detected the 
expression of PRD-1 tagged by V5. The Western blotting results showed no evidence that the 
PRD-1-V5 is rhythmically expressed. However, these results are not sufficient to 
demonstrate the expression of prd-1 is not rhythmic. There are two objections to their 
conclusions. The first point is that the prd-1 mRNA was not assayed. The prd-1 mutation 
causes abnormal splicing of the mRNA of prd-1 which happens after transcription. Even 
though the activity of the promoter of prd-1 is not rhythmic, it is not clear if the pre-mRNA 
is rhythmically regulated by other processes such as splicing or degradation resulting in the 
rhythmic expression of prd-1 mRNA. Only by assaying the mRNA expression level can this 
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be elucidated. The second one is that the PRD-1 was not assayed under physiological growth 
conditions. The paper claimed that the glucose concentration alters the period of the prd-1 
mutant and the PRD-1-GFP relocalized to the cytoplasm in starvation conditions, which 
suggested that the carbon supply influences the function of PRD-1. However, they grew the 
samples for the circadian time course in a fixed volume of liquid medium over a few days 
and extracted protein from them for the Western blotting. The concentration of glucose is 
decreasing while the tissue is growing so that some of the samples must be starved when 
harvesting. In this case the expression of PRD-1-V5 does not represent the situation of normal 
growth. For these reasons, we conducted experiments to detect the expression level of prd-1 
mRNA and PRD-1-FLAG of samples that grow on solid agar medium, in order to assure 
constant glucose supply while growing and simulate the natural mode of growth of 
Neurospora crassa.  
The period of every strain is determined on the race tubes which contains Vogel’s 
medium with 0.5% maltose, 0.17% arginine and 2% agar. As mentioned above, the 
expression of prd-1 may be influenced by carbon sources. Hence, to make sure the period on 
plates is consistent with that on the race tubes we decided to grow the fungus on the same 
medium.  
One of the features of the endogenous circadian clock is that the rhythm is maintained 
without any zeitgebers (time giver). After removing the light, the expression of light-
regulated genes will change. Only the genes involved in or controlled by the molecular clock 
will keep being expressed rhythmically even if the light has been removed for a certain time. 
Hence, samples are collected after one circadian cycle has passed in the dark. 
  
51 
3.2 Materials and Methods 
3.2.1 Strains  
All the strains from lab stock will be identified using their stock number and simplified 
name. The characteristics of strains are displayed in parenthesis. The entire genotype of each 
strain is specified in Appendix A. All the strains analyzed in this chapter carry bd csp-1 chol-
1 mutations except #438, a strain was obtained from FGSC (FGSC#10377) expressing 
FLAG-Pcna, used as the positive control in Western Blotting. 
3.2.2 Race tube assay 
Refer to 2.2.3. 
3.2.3 Protein extraction  
Conidia were inoculated in 1 ml Vogel’s medium with 2% glucose into each well of 24-
well microtiter plates and incubated in LL (constant light) at 30°C for 36 hours (or 22°C for 
3 days) until mycelial disks formed. Mycelia were collected by transferring disks onto wet 
filter paper in a Buchner funnel on a vacuum flask using aspirator for vacuum. Disks were 
washed with distilled water and each disk was put in a microcentrifuge tube with a hole poked 
in the top with a needle. Samples were frozen in liquid N2 and store at -80°C. The frozen 
tissue was ground in liquid-nitrogen-cooled mortar and the powder was transferred to 
microcentrifuge tubes on ice. The volume of powder was estimated and an equal volume of 
protein extraction buffer PEB (50 mM Tris pH 6.8, 2% SDS, 10% Glycerol, 5 mM EDTA-
Na2, 1μg/ml Leupeptin, 1μg/ml Pepstatin A, 1mM PMSF) was added. The mixture was 
vortexed vigorously and boiled for 5min. The tubes were centrifuged at 25°C, 12,000g for 
10 min. The supernatant was removed to new tubes for DC protein assay (BioRad) as 
instructed by the manufacturer. The calculated protein was measured to 20 µg and PEB was 
added to 10 µl. Protein samples were boiled and loaded onto SDS-PAGE gel with equal 
volume (10 µl) of 2X loading buffer (0.125 M Tris-HCl pH 6.8, 4% SDS, 10% 2-
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mercaptoethanol, 10% glycerol, 0.004% bromphenol blue).  
3.2.4 Nuclei isolation 
The mycelia were grown in 100ml Vogel’s medium with 2% glucose in 500ml flasks at 
25°C for three days. Tissue (5-6g) was harvested and washed in double distilled water by 
filtration. The tissue was frozen and ground in liquid nitrogen until very fine powder using 
mortar and pestle. The powder was homogenized with pestles in 9 mL of Buffer A (1M 
sorbitol, 7% Ficoll-400, 20% glycerol, 5mM Mg acetate, 5mM EGTA, 3mM CaCl2, 3mM 
DTT, 50mM Tris-HCl, pH 7.5) and incubated on ice for 5min. 18 mL of buffer B (10% 
glycerol, 5mM Mg(AC)2, 5mM EGTA, 25mM Tris-HCl, pH 7.5) was added slowly with 
stirring. The homogenate was layered (using pipette to make it flow slowly along the wall of 
a 50ml tube) onto 5ml Buffer C (1.85ml Buffer A+3.15ml Buffer B) and centrifuged at 3,000g 
for 7min at 4°C to remove cell debris. The resulting supernatants were removed and carefully 
layered onto 5ml buffer D (1M sucrose, 10% glycerol, 5mM Mg acetate, 1mM DTT, 25mM 
Tris-HCl, pH 7.5) in 40ml centrifuge tubes. The tubes were centrifuged at 9,400g for 15min 
at 4°C to pellet the nuclei. The supernatant (keep it as cytoplasmic fraction) was removed 
and the nuclei were suspended with 1ml Buffer E (25% glycerol, 5mM Mg acetate, 3mM 
DTT, 0.1mM EDTA, 25mM Tris-HCl, pH 7.5). The resuspension was stored at -80°C. All 
buffers contained protease inhibitors 1μM leupeptin, 1μM pepstatin A and 50μM PMSF. 
Proteins were then extracted following the SDS extraction protocol (3.2.3). 
3.2.5 Western blotting and immunodetection 
Proteins were separated by 12% Acrylamide/Bis SDS-PAGE (Appendix B) in running 
buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) at 50 mA per gel for about 45 minutes. 
Proteins were transferred to PVDF membrane (Immobilon-P, Millipore) as instructed by the 
manufacturer. Membranes were blocked in blocking buffer (10 mM Tris, pH 7.5, 150 mM 
NaCl, 0.05% Tween 20, 0.5% skim milk powder, 0.5% BSA) for 60 min and incubated with 
anti-FLAG® M2 antibody (Sigma-aldrich) in blocking buffer for 1 hour at room temperature. 
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After three washes with TBST (10 mM Tris, pH 7.5, 150 mM NaCl, 0.05% Tween 20), the 
tagged proteins were detected using horseradish-peroxidase-conjugated (HRP) secondary 
antibodies and Immobilon ECL reagents (Millipore) as instructed by the manufacturer. 
3.2.6 Genomic DNA extraction 
Conidia were inoculated in 1 ml Vogel’s medium with 2% glucose into each well of 24-
well microtiter plates and incubated in LL (constant light) at 30°C for 36 hours (or 22°C for 
3 days) until mycelial disks formed. Mycelia were collected by transferring disks onto wet 
filter paper in a Buchner funnel on a vacuum flask using aspirator for vacuum. Disks were 
washed with distilled water and each disk was put in a microcentrifuge tube with a hole poked 
in the top with a needle. Samples were frozen in liquid N2 and store at -80°C. The frozen 
tissue was ground in liquid-nitrogen-cooled mortar and the powder was transferred to 
microcentrifuge tubes with 600μl of DNA extraction buffer (100mM Tris-HCl pH 8.0, 50mM 
EDTA, 1% SDS) and proteinase K on ice. The tubes were vortexed and incubated at 65°C 
for 60 min. The cell debris was removed by centrifuging at 14,000g, 4°C for 5min. The 
supernatant was incubated at 37°C for 60 min with 5μl RNase solution (10mM Tris pH 8.0, 
50% glycerol, 10mg/ml RNase) and 200μl of 7.5M ammonium acetate. The mixture was 
cooled on ice for 5 min and mixed with 500μl chloroform. The tubes were centrifuged at 
14,000g, 4°C for 5min. The supernatant was mixed with 650μl isopropanol and centrifuged 
at 14,000g, 4°C for 15 min. The pellet was washed with 1 ml 70% ethanol and centrifuged at 
7,500g, 4°C for 5 minutes. The supernatant was removed and he pellet was dried on the sterile 
bench. The DNA was dissolved with proper amount of double distilled water and the 
concentration was measured by NanoDrop™ 2000/2000c Spectrophotometer 
(ThermoFisher).  
3.2.7 Regular PCR 
Refer to 2.2.6. 
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3.2.8 Techniques related to molecular cloning 
Refer to 2.2.8. 
3.2.9 Transformation of Neurospora 
Refer to 2.2.9.  
3.2.10 Spore PCR 
Refer to 2.2.4. 
3.2.11 Microconidia preparation 
Refer to 2.2.2. 
3.2.12 Crossing  
Refer to 2.2.10. 
3.2.13 Culture and harvest of time courses  
Strains were grown on the surface of cellophane on Vogel’s medium (Appendix B) with 
0.5% maltose, 0.01% L-Arginine, 2% agar and 100µM choline in 150 mm Petri plates. To 
begin with, the spores from the lab stocks were inoculated on a starting plate containing the 
same medium without cellophane pieces laid on the medium and incubated at 30°C LL for 
two days. Agar plugs were made by plugging the wider end of the Pasteur pipette into the 
agar medium at the growth front and the plugs were transferred onto the cellophane surface 
to the edge of the plates. The mycelia of each strain for the inoculation onto each plate came 
from one starting plate. The inoculated cellophane plates first were incubated in LL at 30°C 
and then transferred to DD at 22°C. To collect samples every four hours over 48 hours after 
the transfer to DD, the time points for the transferring and harvesting were scheduled as Table 
3.1. The growth fronts of mycelia were scraped off from the cellophane surface using 10 mm-
wide spatulas in the dark under the red safe-light and frozen in microcentrifuge tubes with 
liquid nitrogen.  
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Table 3.1 The schedule for sampling every 4 hours between 24-72 hours after transferring into dark. 
H stands for the harvesting time. Inoc represents inoculation time. 
 
3.2.14 Coomassie blue staining 
The membrane was washed in distilled water for 10 min and rinsed in 100% methanol 
for 1 min until it is totally wet (transparent). The membrane was then incubated with 
Coomassie blue solution (0.1% Coomassie R-250, 50% methanol, 10% acetic acid) for a few 
minutes until bands were visible. The stained membrane was washed in destaining buffer 
(50% methanol, 10% acetic acid) until bands were clear.  
3.2.15 Digoxigenin (DIG)-conjugated DNA probe 
The DIG-labeled hybridization probe was generated by PCR using the primers 
(NCU07839-1423-F, NCU07839-1636-R), PCR DIG Probe Synthesis Mix (Roche) and Q5 
High-Fidelity DNA Polymerase (NEB). PCR conditions were set following the instructions 
of the manufacturers. The purity of the synthesized probe was tested by agarose gel 
electrophoresis and the concentration was measured by NanoDrop 2000 (ThermoFisher).  
3.2.16 RNA extraction 
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Frozen mycelia were ground to powder using a mortar and a pestle that were pre-cooled 
with liquid nitrogen. The powder was quickly transferred into microcentrifuge tubes 
containing 1ml ice-cold TRI Reagent® (Molecular Research Center, Inc.). Homogenate was 
vortexed and incubated at room temperature for at least 5min. 0.2 ml of chloroform was 
added to the homogenate and mixed by shaking vigorously for 15 seconds. The mixture was 
incubated at room temperature for 15 minutes then centrifuged at 12,000g for 15 min at 4°C. 
The supernatant was removed into 0.5ml isopropanol and the mixture was incubated at room 
temperature for 5-10 min. The RNA is precipitated by centrifugation at 12,000g for 8 minutes 
at 4°C. The RNA pellet was washed with 1 ml of 75% ethanol by vortex and resettled by 
centrifuging at 7,500g for 5 minutes at 4°C. After the RNA pellet was air-dried, the RNA was 
dissolved with various amount of Diethylpyrocarbonate (DEPC) -treated water to bring 
OD260 to about 1. The concentration was calculated by UV spectroscopy. An aliquot of 40µg 
RNA was mixed with 10% volume of 3M sodium acetate and 2 volumes of 95% ethanol and 
incubated at -80°C overnight for complete precipitation. The RNA was pelleted at 12,000g 
at 4°C and washed with 100µl 75% ethanol. The air-dried RNA pellet was dissolved in 5µl 
water + 20µl denaturation cocktail (1X MOPS, 50% formamide, 2.2 M formaldehyde, 0.5 
mM EDTA, 4%glycerol, 0.04% bromophenol blue) and incubated at 75°C for 5 min. Samples 
were cooled on ice for RNA gel electrophoresis. 
3.2.17 Northern blotting and immunodetection 
The RNA was separated on 1.2% agarose MOPS gel with 5% formaldehyde and 1x 
RedSafe (iNtRON Biotechnology). The RNA gel was photographed under the UV light and 
then the RNA was transferred and crosslinked onto BrightStar®-Plus Nylon membranes 
(Ambion) as instructed by the manufacturer. The membrane was hybridized with 0.1ng/ml 
DIG-labeled probe in 10ml ULTRAhyb® Hybridization Buffer (Ambion) as instructed. The 
chemiluminescence was detected using DIG High Prime DNA Labeling and Detection 
Starter Kit II (Roche) and CDP-star® from Brightstar® Biodetect Kit (Ambion). The signal 
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was immunodetected by Anti-DIG Fab-AP with 6 minutes’ exposure. 
3.2.18 Data analysis and statistics 
The chemiluminescence signal was captured and analyzed by MicroChemi Imaging 
System (DNR). The Coomassie blue stained membrane was scanned by the scanner (EPSON). 
The RNA gel was photographed by FluorChem FC2 Imaging System (Alpha Innotech). The 
mean grey values of the bands included by a box with constant dimensions were measured 
using ImageJ (version 1.51, NIH). The brightness of each band was determined by 
subtracting the brightness of the background. The relative expression level of protein was the 
ratio of the measurements of chemiluminescence to the measurements of Coomassie blue 
staining. The relative expression level of RNA was the ratio of the measurements of 
chemiluminescence to the measurements of RedSafe staining on the gel photographs. The 
average relative expression level is normalized as 1. One-way ANOVA (analysis of variance) 
and student’s T-test were executed by Microsoft Excel 2016. 
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3.3 Results 
3.3.1 Preliminary test of PRD-1-FLAG strains from lab stock 
Former lab members constructed his-3+::Pccg-1/Pprd-1::prd-1+::flag/gfp transformants and 
I needed make sure that the strains met the criteria: correct genotype; wild-type phenotype; 
and high expression level of tagged proteins. 
To begin with, I tested the phenotype (race tubes) and genotype (spore PCR) of the 
candidate strains. Only #507 (ccg-prd-1-flag) showed a well-rescued phenotype and the 
phenotype of #519 (native-prd-1-flag) looks close to wild-type (Table 3.1). Spore PCR using 
primers from the his-3 locus showed that expression cassettes have been transformed into the 
genome successfully (Figure 3.1). Regardless of their correct genotypes, I abandoned those 
strains with incorrect phenotype and utilized only #507 and #519 for following experiments.  
As mentioned above, immunoprecipitation is a key step to find proteins that interact with 
PRD-1. It is known that the PRD-1 protein is a nuclear protein and the abundance may be 
low compared with total protein abundance. The ccg-1 promoter is assumed to be a strong 
promoter that could drive higher production of the protein than the native promoter of prd-1. 
Therefore, I planned to isolate nuclear proteins from #507 first to obtain a high concentration 
of FLAG-tagged PRD-1 protein. Because our lab had not done immunoprecipitation or nuclei 
isolation before, I needed to verify the method and test its efficiency.  
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Table 3.2 The results (Mean ± SE, n=5) of race tube analysis to test the phenotype. #26, #260 are 
controls. All other strains also carry the chol-1 and prd-1 mutations. 
strain condition period (hour) 
growth rate 
(mm/hour) 
#26 (chol-1) 
100μM choline 22.2±0.12 1.34±0.04 
No choline 63.0±5.74 0.5±0.02 
#260 (chol-1 prd-1) 
100μM choline 24.6±0.13 0.77±0.01 
No choline 126.3±16.86 0.40±0.02 
#480 (ccg-prd-1-gfp) 
100μM choline 24.9±0.1 1.0±0.01 
No choline 82.5±2.65 0.43±0.01 
#490 (native prd-1) 
100μM choline 19.8±0.29 1.18±0.01 
No choline arrhythmic 0.58±0.01 
#506 (ccg-prd-flag) 
100μM choline 23.5±0.12 1.06±0.02 
No choline 69.4±1.81 0.46±0.01 
#507 (ccg-prd-flag) 
100μM choline 22.2±0.02 1.17±0.01 
No choline 66.4±6.75 0.46±0.02 
#519 (native prd-1-flag) 
100μM choline 21.8±0.34 0.96±0.01 
No choline 60.0±2.66 0.47±0.01 
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Typically, SDS protein extraction buffer is used to extract total proteins in a harsh way, 
but IP buffer extracts protein in a gentle manner to protect protein-protein interactions with 
less concentrated detergent. The nuclear protein may not be extracted by IP buffer thoroughly 
due to the low capability to disrupt the nuclear envelope. Moreover, whether the components 
in nuclei isolation buffer could affect the extraction or protein binding needed to be examined 
as well. Therefore, I ran proteins extracted from #1 (WT) and #507 (ccg-prd-1-flag) by three 
different buffers (without doing nuclei isolation) on SDS-PAGE gel. A positive control (#438) 
which came from a strain expressing a FLAG-tagged protein irrelevant to prd-1 was also 
loaded. The FLAG tag was detected by Anti-FLAG M2 antibody.  
I obtained similar results from different extraction buffers and both strains (Figure. 3.2). 
PRD-1 has a size of 61 kDa. Weak bands at about 63kDa can be observed from the membrane. 
Different buffers seem not to be different when extracting proteins. However, the brightness 
of bands from #1 and #507 is much lower than that from the positive control. It may be 
explained by low abundance of PRD-1. 
Next, I tried to isolate the nuclei and extract concentrated nuclear protein with IP buffer. 
The nuclear protein was concentrated after nuclei isolation since a brighter band showed up 
at the right position. Yet no significant difference could be seen between #1 and #507, 
suggesting that what I acquired may just be concentrated non-specific bands (Figure 3.3).  
The FLAG-tagged strain did not show a positive result, which indicates that the PRD-1-
FLAG protein is not expressed efficiently. In fact, it is implied in my first result because the 
picture was obtained after 7 minutes’ exposure whereas the positive control showed a very 
strong signal with only a 40-second exposure. 
Why couldn’t the successfully transformed strain express FLAG-tagged protein? A doubt 
was raised that something was wrong at the tag region. We have two tags that are commonly 
used in the lab – FLAG and GFP. In case those transformants with tagged PRD-1 protein 
have the wrong tag or no tag in the genome, I tested the genomic DNA of all PRD-1-FLAG 
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transformants in lab stocks by PCR with primers (NCU07839-3136-F, pBM61-1) accurately 
targeting the tag region. Surprisingly, all prd-1-flag transformants which have the ccg-1 
promoter are in fact GFP-tagged strains, and transformants which have the prd-1 promoter 
are FLAG-tagged strains (Figure 3.4). However, I double-checked the sequence of the prd-1 
promoter which was transformed by the former student and found it is hundreds of base pairs 
shorter than the one in the database (FungiDB). Hence, all the FLAG-tagged strains in lab 
stock are unqualified for future experiments. 
Figure 3.1 Spore PCR results of some prd-1 transformants in Table 3.1. Two replicates of each strain 
were loaded. The sizes of target bands are 2kb (WT) and 5~6kb (transformed). 
Figure 3.2 Western Blotting results by Anti-FLAG M2 antibody (7 min exposure). Arrow indicates 
where PRD-1 protein should be. Protein extracted by different protein extraction buffers: SDS, 
immunoprecipitation (IP) and nuclei isolation (NI) buffer. P: positive control. 
  
6kb 
2kb 
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Figure 3.3 Western Blotting results by Anti-FLAG M2 antibody (7 min exposure). Arrow indicates 
where PRD-1 protein should be. Protein extracted after nuclei isolation. P: positive control. 
 
 
Figure 3.4 PCR of genomic DNA to test epitope tag. #471-476, #493-507: ccg promoter; #477-479, 
#484-486, #519-520: native promoter. GFP tag (1.2kb) is larger than FLAG tag (0.8kb). 
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3.3.2 Construction of ccg-prd-1-flag plasmid 
The test above demonstrated that the GFP-tagged strains with the ccg promoter were 
mistakenly labelled as FLAG-tagged strains. As a result, I needed to construct a ccg-prd-1-
flag plasmid targeting the his-3 locus to construct the corresponding N. crassa strain. To 
achieve this, I introduced SpeI and PacI sites to both ends of prd-1 coding sequence by PCR 
(PacI-NCU07839-3503-R, SpeI-NCU07839-1040-F) and then ligated the digested DNA 
segments to the plasmid (Figure 3.5). The backbone is digested from pCCG-C-Gly-3XFLAG 
obtained from FGSC. Both colony PCR and plasmid digestion tests gave the expected result 
(Figure 3.6). The first round of sequencing failed and the second round of sequencing using 
a new set of longer primers confirmed that one of my clones has the correct sequence. 
3.3.3 Construction of native-prd-1-flag plasmid 
Although the ccg-1 promoter may lead to a better expression of PRD-1, it is more 
persuasive if our results are collected from strains with Flag-tagged protein driven by the 
native promoter. It is also necessary to use native promoter for measuring the normal 
expression levels of the PRD-1 protein. When I was analyzing the incorrect transformants, I 
found that the ‘native promoter’ of the plasmid that was used for the transformation was 
missing a section of sequence at the 5’ upstream region, when compared with the sequence 
data from FungiDB.org. Therefore, I planned to construct a new plasmid with the entire 
native promoter and upstream region.  
My initial strategy was to attach the segment of missing sequence to the incorrect 
plasmid by NotI and XbaI (Figure 3.7). The colony PCR of the bacteria transformed by the 
ligated plasmid showed only #2, 5 had correct but very faint bands (Figure 3.8). I extracted 
plasmids from those colonies and did restriction enzyme tests which failed because the XbaI 
is dam methylation sensitive and the cutting site happened to be blocked by methylation. 
Since no more suitable cutting sites can be used to identify the insert, I had to give up this 
strategy.  
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Figure 3.5 Plasmid map of pBM61-ccg-prd-1-flag. 
 
Figure 3.6 Construction of pBM61-ccg-prd-1-flag. Expected bands are annotated beside the 
pictures. a) Colony PCR to select transformed E. coli cells. Primers: native-prd-1 up-F (Not I), 
native-prd-1 up-R (Xba I). b) Restriction enzyme digestion (SpeI and PacI) of colonies from a).  
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My second strategy was to insert the whole cassette: native promoter and prd-1 wild-
type gene without the stop codon, into an original backbone plasmid with the his-3 gene and 
the sequence of FLAG (pCCG-C-Gly-3XFLAG) (Figure 3.7). I amplified the insert fragment 
from wild-type genomic DNA by PCR with Not I and Pac I sites introduced (native-prd-1 
up-F (Not I), PacI-NCU07839-3503-R). After digestion by NotI and PacI, the purified insert 
and backbone fragments were ligated and transformed into 10-beta E. coli competent cells. 
For the first trial, I failed to obtain colonies that could grow in the liquid LB medium. For the 
second and third trial, I obtained a total of 15 colonies that were discovered to be the parent 
vector. Considering that the backbone plasmid may not be thoroughly digested and super-
coiled uncut plasmid will run at the same position on the gel with the cut backbone fragment, 
I cannot separate them by gel purification. Thus, for the fourth trial, I did a two-step digestion 
for both fragments, and as a result, the colonies were not backbone plasmid even though still 
not what I wanted (Figure 3.9). When the fifth trial also failed, I was advised that NotI cannot 
digest PCR products completely if the cutting sites are located at the end of DNA and I should 
do subcloning to ligate fragments into T-vectors or blunt-end vectors. The insert was cloned 
into pJET (Thermofisher) successfully (Figure 3.10). For the sixth trial, I ligated the purified 
digested fragments from both the subclone and the backbone plasmid. I found that all the 
colonies were pJET-native-prd-1 subclones. Due to the fact that the size of the pJET vector 
is similar to the insert, in order to separate them, I digested the subclones with BspHI to cut 
up the vector.  
Finally, I harvested my anticipated plasmid on the seventh trial (Figure 3.11) and sent it 
for sequencing. Unfortunately, two base pairs (C and T) were found missing in the CT-
repetitive region in the first intron of the prd-1 gene. Is this plasmid acceptable? RT-PCR of 
the prd-1 mutant showed that the mutated prd-1 gene can be spliced alternatively which leads 
to the aberrant phenotype (Adhvaryu et al., 2016). Thus, no error is acceptable in the plasmid 
even in an intron. Sequence errors may come from the genomic DNA as the template of the 
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amplified insert or via PCR. Therefore, I amplified a small region which contains the first 
intron of the prd-1 gene from both transformed bacteria and WT strains. Sequencing results 
revealed that the sequence of our WT strains in our lab is identical to the sequence from the 
database. As a consequence, I should reconstruct the plasmid.  
I amplified the prd-1 transcript from the sequenced genomic DNA, and then ligated it 
into the blunt-end vector pJET (Thermofisher) (Figure 3.12a). I sent the subclones for 
sequencing to make sure that the sequence of pJET-native-prd-1 was not mutated. 
Purification of the NotI/PacI-digested subclone and backbone plasmid was then followed by 
the ligation. Eventually, I selected and sequenced a correct plasmid from dozens of colonies 
after several transformations (Figure 3.12 b and c). 
 
Figure 3.7 Plasmid map of pBM61-native-prd-1-flag. 
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Figure 3.8 Colony PCR result of native-prd-1-flag plasmids with primers used for amplifying insert 
DNA segment. 
Figure 3.9 Restriction enzyme test of native-prd-1-flag transformants. Before the ligation, two-step 
digestion was carried out to remove parent vector pCCG-Gly-FLAG. The correct plasmid should 
produce two bands 7.0kb and 3.5kb. M: 1kb DNA ladder; V: parent vector. 
Figure 3.10 Restriction enzyme test of pJET-native-prd-1 subclones. The size of backbone fragment 
is 3.0kb and insert fragment is 3.5kb.  
Figure 3.11 Restriction enzyme test of pBM61-native-prd-1-flag transformants. The 3.5kb DNA 
fragment is inserted into vector successfully. V stands for backbone vector pCCG-Gly-FLAG 
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Figure 3.12 Construction of native-prd-1-FLAG. Expected bands are annotated beside the pictures. 
a) Restriction enzyme digestion (NotI and PacI) of putative pJet-native-prd-1 plasmids from selected 
colonies. #1,5,10,14 have correct bands. b) PCR of native-prd-1-FLAG E. coli colonies using the 
primers native-prd-1 up-F (Not I) and native-prd-1 up-R (Xba I). P: pJET-native-prd-1. c) Restriction 
enzyme digestions of pBM61-native-prd-1-FLAG #3. M: 1kb ladder. A: NdeI, NotI and XbaI. 
expected bands: 5.7kb, 4kb, 0.9kb. B: HindIII. Expected bands: 6.9kb, 2.7kb, 1kb. 
  
a 
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3.3.4 Construction of transformants expressing FLAG-tagged PRD-1  
Once the plasmids were obtained, the next step was transformations of Neurospora. The 
plasmids have a his-3 targeting region which is a partial sequence of the his-3 gene. The 
transformed spores will no longer be histidine deficient and untransformed spores will not 
grow on the medium without histidine. However, as the recipient, macrospores possess more 
than one nucleus. Indeed, only a few nuclei will be transformed. Therefore, I needed to isolate 
homokaryotic strains whose nuclei all carry the transformed genome. Two methods are 
commonly used for homokaryon purification - microconidia isolation and crossing.  
3.3.4.1 Ccg-prd-1-flag 
I transformed the ccg-prd-1-flag plasmid into macrospores of a his-3 mutant #274 
(histidine-requiring strain) after the midi preparation of the plasmid. I transformed linearized 
highly concentrated plasmid into fresh spores and obtained dozens of colonies. Subsequently, 
spore PCR showed that all of them were heterokaryons (having both transformed and 
untransformed nuclei). To obtain homokaryons, I chose three colonies which had highest 
portion of transformed nuclei for microconidia purification. Two microconidia purifications 
failed to isolate homokaryons. Meanwhile, since we are interested in the FRQ-less oscillator, 
I also started to cross the heterokaryons with a frq10 strain to get strains with the frq knockout 
background. Ascospores showed a very low germination ratio so that only three ascospores 
germinated out of 100 picks. A more efficient way to select homokaryons is to pour thousands 
of ascospores on the sorbose medium in the Petri plates to isolate colonies, even though 
pouring 200 ascospores in one plate may result in heterokaryons. I identified 3 homokaryons 
from 50 colonies by spore PCR (Figure 3.13a), and then I ran a race tube test (Table 3.2) and 
a hygromycin test to determine their genotype. Finally, I obtained two homokaryons such 
that one has the frq+ background (#586) and the other has the frqKO background (#587) 
(Figure 3.13b).  
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3.3.4.2 Native-prd-1-flag 
I transformed the native-prd-1-flag plasmid into two recipient strains #274 (prd-1+) and 
#310 (prd-1-). For the transformants with WT background, I proceeded with microconidia 
purification and attained one homokaryon (#588) as shown by spore PCR (Figure 3.13d). For 
the transformants with prd-1 background, I obtained a homokaryotic transformant with prd-
1 mutation background directly from transformation (Figure 3.13c). The phenotype of the 
strains were analyzed by the race tube assay (Table 3.2). 
Table 3.3 The results (Mean ± SE, n=3) of race tube analysis to test the phenotype. #26, #80 are 
controls. All other strains also carry the chol-1 mutations. 
strain condition period (hour) 
growth rate 
(mm/hour) 
#26 
 (chol-1) 
100μM choline 21.3±0.06 1.41±0.01 
No choline 47.1±2.11 0.46±0.02 
#80 
 (chol-1 frqKO) 
100μM choline arrhythmic 1.40±0.002 
No choline 53.3±1.65 0.48±0.01 
#586  
(ccg-prd-1-flag) 
100μM choline 26.8±0.92 0.98±0.02 
No choline 59.2.5±8.66 0.45±0.02 
#587  
(ccg-prd-1-flag frqKO) 
100μM choline arrhythmic 1.23±0.01 
No choline 45.0±2.38 0.51±0.01 
#588  
(native-prd-1-flag) 
100μM choline 22.3±0.06 1.1±0.02 
No choline 51.88±4.96 0.45±0.02 
#589  
(native-prd-1-flag prd-1-) 
100μM choline 20.6±0.02 1.28±0.03 
No choline 56.0±2.68 0.56±0.02 
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Figure 3.13 Construction of transformants expressing FLAG-tagged PRD-1. a) Spore PCR of ccg-
prd-1-FLAG crossing progenies using primers targeting his-3 locus (His3-F1 and His-3R2) to select 
homokaryons. Transformed nuclei shows a 5.5kb band. b) Spore PCR of homokaryons from a) 
using frq primers targeting frq locus. Wild type frq shows a 500bp band. #6: frq+, #28: frq10, #36: frq 
heterokaryon. c) Spore PCR of native-prd-1-FLAG transformants with the prd-1 mutant 
background using primers targeting his-3 locus (His3-F1 and His-3R2). Transformed nuclei shows a 
5.5kb band. d) Spore PCR of colonies from microconidia purification of native-prd-1-FLAG 
transformants with prd-1+ backgound using primers targeting his-3 locus (His3-F1 and His-3R2). 
a 
b 
c 
d 
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3.3.5 The rhythmicity of the prd-1 mRNA 
3.3.5.1 The generation and efficiency test of DIG-labeled DNA probe 
To detect the mRNA of the prd-1 gene by Northern blotting, a DIG-labeled probe has to 
be specifically targeting the transcript of prd-1. Avoiding any potential alternative splicing at 
the C-terminus, I chose a ~200nt probe from the N terminus of the prd-1 gene excluding the 
introns (see the sequence in Appendix D). The probe was aligned with the whole genome of 
Neurospora crassa showing that the probe sequence is highly specific.  
Since the DIG-labeled dNTP will impact the amplification, the production of a DIG-
labeled probe is not as high as a normal PCR product. Additionally, the probe cannot be 
purified by gel purification. Therefore, I needed to optimize PCR conditions to ensure that 
no non-specific products are amplified. I amplified unlabeled probe with different annealing 
temperatures and different templates. The agarose gel electrophoresis showed a single bright 
band that was amplified from plasmid DNA annealing at 66°C (Figure 3.14a). When using 
DIG-labeled dNTP mixture, the size of the PCR product appeared to be significantly larger 
than the unlabeled DNA fragment (Figure 3.14b). According to the DIG-labeling Kit 
instructions, the labeled probe migrates slower on the agarose gel. Thus, I believe I have 
amplified the correct DIG-labeled probe.   
To test the efficiency of this probe, I prepared RNA from both wild type and the prd-1 
mutant on both liquid and solid media. I tried 1ng of DIG-labeled probe to hybridize with 
40μg of total RNA. Northern blotting demonstrated that 1ng of my probe is sufficient for the 
detection and the prd-1 mutant has a higher expression level of prd-1 mRNA (Figure 3.15). 
No significant difference of the chemiluminescence can be seen between agar plates and 
liquid medium.  
  
73 
Figure 3.14 DNA probes in the 1.5% agarose gel. a) unlabeled probe is amplified from plasmids 
under the following PCR conditions: 98°C 30sec, 66°C 30sec, 72°C 30sec for 32 cycles. Four 
replicates were run on the gel. b) Both unlabeled and labeled probes are amplified under the same 
PCR conditions. The labeled probe has a slower migration rate. 
Figure 3.15 Agarose gel (upper panel) and Northern blot (lower panel) of 40µg total RNA of WT 
(#26) and prd-1 mutant (#260) from solid or liquid culture. Three replicates of each sample are 
loaded on the gel.   
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3.3.5.2 The expression of the prd-1 mRNA is not circadianly rhythmic 
Once the probe was verified, I prepared samples for the time course. To assay the 
expression level of wild-type mRNA of prd-1, I chose #26 (prd-1+) for subsequent 
experiments.  
I collected 13 samples every 4 hours from 24 hours to 72 hours after the plates were 
transferred into constant dark at 22°C. 40µg total RNA of each sample was loaded on the 
RNA gel and Northern blotting was carried out. I conducted the experiments five times and 
I used the last four results for quantification because of uneven loading in the first trial.  
On the gel, the amount of 28S rRNA is roughly twice as much as 18S rRNA and both 
have clear bands (Figure 3.16a) indicating that the RNA sample was not degraded. When 
comparing the membrane with RNA gel, the signal is mainly located at the position of 28S 
rRNA.  
Using compiled data of four independent trials, Figure 3.16b shows that the expression 
levels of prd-1 mRNA fluctuate slightly but not rhythmically. Particularly, a period about 24 
hours cannot been observed. The standard errors are relatively high compared to the means. 
ANOVA reveals that no significant difference of expression level exists among 13 time points. 
Therefore, the expression of prd-1 mRNA is not circadianly rhythmic. 
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Figure 3.16 The results of circadian time course of the prd-1 mRNA. a) Representative picture of 
immunodetected membrane and RNA gel. b) Relative expression levels of the mRNA of prd-1 over 
48 hours. Mean ± SE is shown (n=4). P= 0.7571 (one-way ANOVA). 
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3.3.6 The rhythmicity of PRD-1 
3.3.6.1 Preliminary test of #588 (native-prd-1-flag) 
As mentioned in 3.3, 4 strains expressing PRD-1-FLAG were confirmed to be qualified 
for subsequent experiments. Initially, I needed to check the expression level of the tagged 
protein. I grew the fungus in constant light in liquid medium at 25°C. I extracted protein and 
ran Western blotting with M2 Anti-FLAG antibody. The results implied that all transformed 
strains have a high expression level of tagged protein (Figure 3.17).  
 
Figure 3.17 Western blotting results using Anti-FLAG M2 antibody (Exposure time 1 min). The 
arrow indicates where PRD-1-FLAG should be. #26: WT; #80: frq10; #586: ccg-1-prd-1-FLAG; #587: 
ccg-1-prd-1-FLAG, frq10; #588: native-prd-1-FLAG; #589: native-prd-1-FLAG, prd-1-. 
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3.3.6.2 The expression of PRD-1-FLAG is not circadianly rhythmic 
Once the expression of PRD-1 was confirmed, I prepared samples for the time course. 
Since #588 expresses the PRD-1-FLAG driven by the native promoter, the results from it 
should be more accurate than the results from the strains containing the ccg-1 promoter. To 
study the rhythmicity of PRD-1, I chose #588 for subsequent Western blotting.  
I collected 13 samples every 4 hours from 24 hours to 72 hours after the plates were 
transferred into constant dark at 22°C. I conducted the experiments five times and I used all 
five results for quantification. 
From the chemiluminescence (Figure 3.18a), we cannot observe rhythmic expression of 
FLAG-tagged PRD-1. However, the integrated results from all five trials displayed 
fluctuations (Figure 3.18b). The analysis of variance confirmed that the PRD-1 expression 
level at 13 time points are significantly dissimilar (P=0.03). When comparing the peaks and 
troughs, significant differences presented between 24h and 32h, 32h and 44h, 48h and 60h. 
It seems to implicate a period about 16 hours to 20 hours. The peaks have only 1.5-2 fold 
expression above the troughs which is not a dramatic expression level. Hence, the expression 
level of PRD-1 does fluctuate to some extent, yet it is not circadianly rhythmic. 
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Figure 3.18 The results of circadian time course to assay PRD-1-FLAG. a) Representative picture 
of immunodetected membrane and Coomassie blue stained membrane. M: BLUeye Pre-stained 
Protein Ladder (GeneDireX). Five bands of the ladder are shown (from top to bottom, about 75, 63, 
48, 35, 25kDa) b) Relative expression levels of PRD-1-FLAG over 48 hours. Mean±SEM are 
shown (n=5). *: P<0.05 (student’s T test). N.S.: not significant P>0.05 (student’s T test). P= 0.03 
(one-way ANOVA). 
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3.4 Conclusion 
When I attempted to detect the expression of PRD-1-FLAG extracted from strains 
constructed by previous lab members, the Western blot showed that no difference could be 
detected between WT and ccg-prd-1-flag transformants. Further analysis of the DNA 
sequences revealed that the former strains are not appropriate for Western blot and IP. Hence, 
I constructed the plasmids containing the prd-1-flag expression cassette and transformed 
them into Neurospora crassa. Homokaryons were obtained by microconidia or ascospores.  
The prd-1 mutant expresses only a small proportion of normally spliced mRNA and the 
phenotype is altered. This may imply that the dosage of PRD-1 influences the phenotype. 
Since the transformants have more than one copy of prd-1, either wild-type or mutant, the 
phenotype might be altered. The period and growth rate of the transformants are slightly 
different from the WT strain on race tubes, which is consistent with our hypothesis. 
In this chapter, the rhythmicity of the expression level of the prd-1 gene was examined. 
Samples of WT and PRD-1-FLAG-expressing strains were collected from 24th hour to 72nd 
hour after transfer into constant dark. The mRNA of prd-1 was detected by DIG-conjugated 
DNA probe utilizing Northern blotting. The PRD-1-FLAG was detected by Anti-FLAG 
antibody using Western blotting.  
The data demonstrated that the mRNA and the protein of prd-1both are not expressed in 
the pattern of a circadian rhythm. In spite of some fluctuation of prd-1 mRNA, the variation 
is relatively high at each time point. The ANOVA showed that no significant difference exists 
during 48 hours. As for the protein level, regardless of a significant change between peaks 
and troughs, the durations of the oscillation are more like 16 hours which is different from 
the period of the free-running rhythm, 22 hours (Table 3.2) (Figure 3.19). 
In summary, the prd-1 gene is unlikely to be a component of or directly controlled by the 
circadian clock in Neurospora crassa.  
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Figure 3.19 Representative picture of the race tubes of wild type (#26) and native-prd-1-flag strain 
(#588). The strains were grown on the same medium as the one used in the time courses. The race 
tubes were incubated at 30°C, LL for 1day and then at 22°C, DD for about 10 days. 
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Chapter 4  Interacting partners of PRD-1 
4.1 Introduction 
Co-Immunoprecipitation (Co-IP) is a key step to identify proteins that interact with 
PRD-1. PRD-1 is homologous to the DEAD-box RNA helicase family. The function of RNA 
helicases is extremely various (Linder and Jankowsky, 2011). It is difficult to determine what 
roles PRD-1 is playing by simply referring to the functions of RNA helicases. Identifying the 
binding partners of PRD-1 will offer clear guidance to understand the function of PRD-1. 
Another DEAD-box RNA helicase FRH (FRQ- binding RNA helicase) is found to regulate 
the TTFL in N. crassa by binding to FRQ (Cheng et al., 2005). The PRD-1 protein may also 
interact with the components that are involved in the circadian clock. Thus, I planned to pull 
down the proteins binding to PRD-1 and analyze them by MS (Mass Spectrometry).  
In Chapter 3, I constructed the strains expressing PRD-1-FLAG driven by the native 
promoter and #588 is appropriate for Co-IP. To acquire more significant results from MS, a 
high abundance of PRD-1-FLAG is preferred. It is known that the PRD-1 protein is a nuclear 
protein (Adhvaryu et al., 2016). The abundance of this nuclear protein may be low compared 
with total protein abundance. Nuclei isolation may be required to obtain a high concentration 
of FLAG-tagged PRD-1 protein. It is reported that the PRD-1-GFP protein is transported to 
the cytoplasm when the cells are starving (Emerson et al., 2015). To identify the nuclear 
binding partners of PRD-1, samples have to be harvested when the glucose has not been 
depleted in the medium. Therefore, tissues will be grown in a high volume of medium for 
only 24 hours.  
 
4.2 Materials and Methods 
4.2.1 Strains and cell culture 
All the strains from lab stock will be identified using their stock number and simplified 
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name. The characteristics of strains are displayed in parenthesis. The entire genotype of each 
strain is specified in Appendix A. #26 (bd csp-1 chol-1) was considered as wild type. The 
FLAG-tagged PRD-1 protein was extracted from #588 (bd csp-1 chol-1 his-3+::native-prd-
1-flag). #444 (bd csp-1 chol-1 NCU05950KO his-3+::NCU05950-flag) was treated as a control 
in Co-IP and MS.  
For the IP experiments that were followed by Western blotting, fresh conidia were 
inoculated in 1ml Vogel’s liquid medium with 2% glucose in a 24-well plate at 25°C for three 
days and harvested when mycelia mat was formed. For Co-IP, fresh conidia were cultured on 
3ml Vogel’s agar medium with 2% glucose in stock tubes. After 7days, mycelia of the whole 
test tube were transferred to 100 ml Vogel’s liquid medium with 2% glucose on a rotating 
shaker at 130 rpm for 24 hours at 25°C, LL. Fresh mycelia were harvested by washing with 
water and filtration, then frozen in liquid nitrogen, and stored at -80°C. 
4.2.2 Nuclei isolation and protein extraction 
Refer to 3.2.3 and 3.2.4.  
4.2.3 Co-IP for Western blotting 
Frozen tissue was ground in liquid nitrogen in mortar and pestle. The powder then was 
mixed with ice-cold IP extraction buffer (50mM HEPES pH 7.4, 150mM NaCl, 1mM EDTA, 
0.02% (v/v) NP40, 10% (v/v) Glycerol, 1μg/ml Leupeptin, 1μg/ml Pepstatin A, 1mM PMSF) 
by inversion and incubated for 5 min at 4°C. Cell debris was pelleted at 15,000g for 15min 
at 4°C. The supernatant was kept as total IP extract. The pellet was resuspended in SDS 
protein extraction buffer (50 mM Tris pH 6.8, 2% SDS, 10% Glycerol, 5 mM EDTA, 1μg/ml 
Leupeptin, 1μg/ml Pepstatin A, 1mM PMSF) and boiled for 5 min. The supernatant from 
boiled tubes was kept as indissoluble proteins after centrifugation at 12,000g for 10 min for 
examining extraction efficiency. The concentration of protein samples was measured with 
DC protein Assay (BioRad). 50µl Sepharose® 4B beads (Sigma-Aldrich) were washed with 
1ml IP extraction buffer and pelleted at 500g, 4°C five times. 10µl Anti-FLAG M2 Affinity 
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Gel (Sigma-Aldrich) was washed with 1ml IP extraction buffer at 500g at 4°C twice and 
incubated with 1ml 0.1M glycine-HCL pH3.5 for 10 min. The gel was washed with 1mL IP 
extraction buffer three more times at 500g at 4°C. The pre-washed unconjugated resin was 
mixed with 1 mg protein of IP extract and incubated on a rotating shaker at about 12rpm at 
4°C for 1hour. Incubated unconjugated resin was centrifuged at 750g for 1min at 4°C and the 
supernatant (kept as Input) was mixed with glycine-incubated M2 Affinity Gel. The mixture 
was incubated on a rotator overnight at 4°C. The affinity gel was precipitated by 
centrifugation at 750g, 1 min at 4°C. The supernatant was kept as Post-IP for capture 
efficiency examination. The affinity gel was washed three times with 1ml IP extraction buffer 
and boiled with 20µl SDS protein extraction buffer. The affinity gel was pelleted down at 
750 g, 25°C and the supernatant was kept as IP-pulldown.  
4.2.4 Western blotting 
Refer to 3.2.5 
4.2.5 SDS-PAGE gel staining  
The SDS-PAGE gel was incubated with the staining solution (10% (NH4)2SO4, 10% 
H3PO4, 20% methanol, 0.12% Coomassie brilliant blue G-250) on a rotating platform at 20 
rpm overnight. The stained gel was washed in double distilled water until the bands were 
clear. The gel was briefly dried and scanned by a scanner.  
4.2.6 Co-IP and Mass Spectrometry 
The Co-IP method is similar to 5.2.3. 10mg proteins in 5ml IP extraction buffer from 
total IP extract were pre-cleared by 50µl pre-washed Sepharose beads in 5ml microcentrifuge 
tubes at 4°C for 1 hour. The supernatant was incubated with 10µl Anti-FLAG Affinity Gel 
overnight on a rotator at 4°C. The affinity gel was precipitated at 750g for 1 min at 4°C and 
washed with 1ml ice-cold IP extraction buffer three times. The gel then was rinsed with 
FLAG-rinsing buffer (50mM NH4HCO3 pH 8, 75mM KCl, 2mM EDTA) twice and stored at 
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-80°C. Frozen beads were sent to SPARC Biocentre (Hospital for Sick Children, Toronto, 
Canada) for the C18 column cleaning, ammonium hydroxide elution, trypsin digestion and 
LC-MS analysis. Four trials conducted by the optimized protocol were analyzed.  
4.2.7 Data analysis 
The results of MS were acquired in Scaffold software (Proteome Software, Inc). The 
sequences of peptides were aligned to NCBI Neurospora crassa OR74A protein database. 
The existence probability of chosen proteins for analysis were above 95%. Two methods 
were applied to select interacting proteins of PRD-1. First, proteins that had more than 3 
appearances and had aggregated total spectrum counts which were at least twofold that of 
both controls were selected. In the second method, if the abundance of a protein from #588 
was at least two times the abundance of one of the controls in a single experiment, the protein 
was assigned one valid count. Proteins that have more than 6 out of maximum 8 valid counts 
were selected.  
 
4.3 Results 
4.3.1 Nuclei isolation is not necessary for IP 
In Chapter 3, #588 was shown to express sufficient PRD-1-FLAG for the 
immunodetection. Typically, SDS protein extraction buffer is used to extract as much protein 
as possible, but IP buffer extracts protein in a gentle manner to protect protein-protein 
interactions. Whether the IP buffer could extract sufficient amount of PRD-1-FLAG needed 
to be examined. Similarly, whether nuclei isolation could concentrate the PRD-1 protein 
needed to be analyzed. Therefore, I extracted proteins of #26 and #588 with IP buffer from 
both whole cell lysate and isolated nuclei pellets. The Western blotting results showed that 
the IP buffer was able to extract proteins from #588 but not thoroughly because a notable 
amount of PRD-1-FLAG could be extracted by SDS protein extraction buffer from the debris 
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(Figure 4.1). However, PRD-1-FLAG was not significantly concentrated after nuclei 
isolation, whereas the non-specific binding proteins were concentrated in nuclear extract of 
#26. This suggested that the nuclei isolation is not a necessary step before IP. 
4.3.2 Capture efficiency of Anti-FLAG M2 Affinity Gel 
Next, I tested the efficiency of M2 Anti-FLAG Affinity Gel binding to the PRD-1-FLAG 
protein. I prewashed the lysate with Sepharose beads to eliminate non-specific binding 
proteins. Prewashed sample (input) was incubated with M2 Anti-FLAG Affinity Gel 
overnight and washed with IP buffer. I boiled the beads with SDS buffer to elute proteins and 
loaded them on SDS-PAGE gel. The Western blot of #588 showed that unconjugated agarose 
beads did not substantially reduce the abundance of PRD-1-FLAG and 10µl affinity gel could 
pull down almost all the tagged PRD-1 protein (Figure 4.2a). Meanwhile, the non-specific 
binding proteins were enriched in the pulled-down proteins of wild type (#26).  
I also stained the SDS-PAGE gel with Coomassie brilliant blue G-250 and tried to 
observe the pulled-down proteins from 10mg of total extract on the gel. The stained gel 
showed that proteins from the affinity gel were dramatically less than the input and several 
clear bands could be seen (Figure 4.2b). However, no isolated band could be observed at the 
putative position of PRD-1-FLAG based on the molecular weight marker.  
The results demonstrated that the methods I used were functioning and the samples were 
acceptable for MS.  
4.3.3 Candidates of PRD-1 binding partners 
The pulled-down proteins binding on M2 Anti-FLAG Affinity Gel were sent to the 
SPARC Biocentre for MS analysis. The sample from #26 (WT) was used as the negative 
control. The sample from #444 (NCU05950-FLAG) was used as a control. Two methods 
were applied to select enriched proteins as described in 4.2.7. The lists from both selection 
methods are highly matched: 37 and 31 proteins were selected from the two methods and 29 
of them appeared in both lists. The complete information of overlapped enriched proteins is 
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listed in Appendix E. In the candidate list, most of the binding proteins of PRD-1 are the 
proteins associating with ribosomes.  
Proteins that are highly enriched (10 fold or more) in my sample are listed in Table 4.1. 
All the binding proteins were ribosomal proteins. Among these 10 candidates, 3 came from 
the small subunit and 7 came from the large subunit. 40S ribosomal protein S6 had the highest 
total count.  
 
Table 4.1 List of candidates binding to PRD-1. Total spectrum counts of each protein from four 
independent trials are aggregated. Proteins from #588 that are 10-fold or more enriched compared to 
both controls are shown. 
Gene 
Name 
Identified Proteins  
Total Spectrum Counts Ratio of Enrichment  
WT 
NCU05950-
FLAG 
PRD-1     
-FLAG 
PRD-1-
FLAG/WT 
PRD-1-FLAG/ 
NCU05950-
FLAG 
NCU08502 40S ribosomal protein S6  1 4 69 69 17.25 
NCU04779 60S ribosomal protein L8 6 6 63 10.5 10.5 
NCU06843 60S ribosomal protein L3  1 4 47 47 11.75 
NCU07829 60S ribosomal protein L7  0 1 44 ∞ 44 
NCU00258 40S ribosomal protein S7 0 1 39 ∞ 39 
NCU02707 60S ribosomal protein L6 0 2 35 ∞ 17.5 
NCU00294 60S ribosomal protein L10a  0 1 31 ∞ 31 
NCU02181 40S ribosomal protein S4 0 1 26 ∞ 26 
NCU08389 60S ribosomal protein L20 0 2 21 ∞ 10.5 
NCU01827 60S ribosomal protein L27 0 1 13 ∞ 13 
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Figure 4.1 Western blotting results detected by Anti-FLAG antibody. 20µg protein was loaded on 
each lane. Arrows indicate where PRD-1 protein should be. Proteins of #26 (WT) and #588 (native-
prd-1-flag) were extracted under different conditions. A: Total protein extracted by SDS buffer; B: 
Total protein extracted by IP buffer; C: supernatant of nuclei isolation (regarded as cytoplasmic 
protein); D: nuclear protein extracted by SDS buffer from isolated nuclei; E: nuclear protein extracted 
by IP buffer from isolated nuclei; F: remaining nuclear protein after IP buffer extraction extracted by 
SDS buffer. 
  
Non-specific bands 
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Figure 4.2 IP capture efficiency assay. a) Western blotting results detected by M2 Anti-FLAG 
antibody. 20µg IP extract protein, 20µg protein binding to Sepharose beads, 20µg Input protein, 20µl 
Post-IP supernatant and 20µl IP-pulldown protein from #26 (WT) and #588 (native-prd-1-flag) were 
loaded. b) Coomassie brilliant blue stained SDS-PAGE gel. 20µl wide range SigmaMarker (M), 20µl 
Input, all pulled-down proteins were loaded on the gel.  
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4.4 Conclusion 
In this chapter, I conducted experiments for Co-IP and MS analysis to discover the 
interacting partners of PRD-1. The IP buffer is satisfactory for immunoprecipitation 
regardless of the relatively low extraction efficiency. The nuclei isolation is not a necessary 
step prior to Co-IP since PRD-1-FLAG was not highly concentrated in nuclear extract, even 
though the nuclear protein was enriched. I sampled from every step in Co-IP and found that 
the pre-clear step with Sepharose beads did not substantially decrease the concentration of 
PRD-1-FLAG and the M2 Anti-FLAG Affinity Gel could pull down most of the FLAG-
tagged proteins.  
Once the methods were validated, experimental samples with controls were sent for MS 
analysis. Based on objective standards, enriched proteins were selected. At the top of the list 
were ribosomal proteins from both subunits. Most of the candidate binding partners were 
ribosomal proteins. These results suggested that the PRD-1 protein may be one of the 
essential components in the ribosome and it may influence the phenotype by affecting 
ribosome biogenesis.  
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Chapter 5  Growth responses under different conditions 
5.1 Introduction 
The prd-1 mutant grows slower than wild type, suggesting that the prd-1 gene may 
regulate the growth of Neurospora. It is possible that the abnormal circadian rhythm of the 
prd-1 mutant is a response to mis-regulated growth. Evidence on the association between 
nutrient sensing and the circadian rhythms is emerging. The altered growth response of the 
prd-1 mutant to different nutrients may reveal the function of PRD-1 in metabolic regulation 
which could account for the abnormal circadian rhythm. Therefore, I planned to assay the 
growth response of prd-1 mutant on different media, attempting to discover hints for the 
function of the prd-1 gene. 
5.1.1 The association between glucose concentration and the prd-1 gene. 
Emerson’s paper showed that the phenotype of the prd-1 mutant is altered in media with 
different carbon availability (Emerson et al., 2015). The period of prd-1- shortened with 
decreasing glucose concentration from 1% to 0% whereas the wild type persisted with the 
normal period. They also reported that PRD-GFP will relocalize to the cytoplasm after 
starvation. These suggest that the prd-1 gene may function differently when the glucose 
concentration is changed. Hence, the prd-1 mutant by altering some of the functions of wild-
type PRD-1 may cause a different growth response to the same medium.  
5.1.2 The association between amino acids and the prd-1 gene. 
The prd-1 mutant abolished the FRQ-less rhythm and the prd-1 gene is considered as a 
component of FLO. UV90, another gene that affects FLO, is found to be involved in the TOR 
pathway, which is crucial for nutrient sensing. Both glutamine and leucine stimulate TOR 
activity in mammals and yeast, with glutamine being the preferred nitrogen source for yeast 
(Stracka et al., 2014). In N. crassa, glutamine is also the preferred amino acid nitrogen source 
for growth. Glutamine is a nitrogen donor and a pivotal compound as a repressor of nitrogen 
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catabolism (Calderon and Mora, 1989). Arginine is another prominent nitrogen source in N. 
crassa. Large amounts of arginine are stored in the vacuole, and released when nitrogen is 
depleted (Davis and Weiss, 1988). I therefore chose to assay the effects of three amino acids: 
glutamine (Gln), arginine (Arg) and leucine (Leu). 
5.1.3 The measurement of growth rate and growth limit 
The growth of organisms can be affected by many environmental factors in many aspects. 
Two general parameters are commonly used to assess the growth: the growth rate and the 
growth limit. Typically, the growth curve is an S-shaped curve which could be defined by 
these two parameters. Neurospora crassa also displays the S-shaped growth curve. However, 
the growth curve varies with different culturing methods. To evaluate the growth response of 
Neurospora with different nutrient sources, the standard growth curve needs to be determined 
first under standard growing conditions. The growth curves with different nutrient sources 
will be compared to the standard curve.  
The prd-1 mutant has a slower growth rate, thus has a distinct standard growth curve to 
the wild type. It is not feasible to detect the growth rate at every time point, but the average 
growth rate can be calculated through a division of the growth by the time required to reach 
that growth. It is difficult to track the exact time needed for the maximum growth under every 
condition and harvest the cells at the precise time. Hence, I planned to sample a time point at 
which the 50% maximum growth is reached on the standard curve to represent the growth 
rate. I also planned to sample a time point at which the maximum growth is reached on the 
standard curve to represent the growth limit. 
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5.2 Materials and Methods 
5.2.1 Strains  
#4 was considered as the wild-type strain and #170 was a prd-1 mutant strain. Both 
strains carried the bd mutation. 
5.2.2 Culture 
The Vogel’s liquid medium contains ammonium nitrate (NH4NO3) as the only nitrogen 
supply. Different amount of glucose (0.125%-1%) or different amino acids (50mM Gln, Arg, 
Leu) were added into the liquid medium. For the media in which the amino acids are the only 
nitrogen source, the amino acids were added to Vogel’s liquid medium without NH4NO3. 
1000 fresh macrospores were inoculated into in 1ml liquid medium in 24-well plates and 
grown at 25°C with constant light.  
5.2.3 The measurement of dry weight 
The 1.5mL microcentrifuge tubes (Progene) were pre-dried at 80°C for two days and the 
weight of tubes was measured. The mycelia were collected through filtration and washed 
with double distilled water. Washed mycelia were then transferred into pre-dried tubes and 
desiccated at 80°C for two days and the weight of tubes containing dried tissues was 
measured. The dry weight of Neurospora crassa was the difference between these two 
measurements.  
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5.3 Results 
5.3.1 The determination of the standard growth curve 
Spores were inoculated to 1ml standard liquid medium (1% glucose Vogel’s medium) 
and mycelia mats were harvested every 24 hours to track the growth curve. The samples were 
desiccated immediately for 2 days after harvesting. The growth curve of 6 days’ growth is 
shown (Figure 5.1). 
Both curves are ‘S” shape. It took wild type about 2 days or the prd-1 mutant nearly 5 
days to reach the growing plateau. The growth limit is about 4mg of WT and about 5mg of 
the prd-1 mutant. The growth rate at exponential stage looks similar. Referring to the standard 
curve, the time points to harvest half maximum growth that are on the midpoint of the ascent 
curve are about 36th hour for WT and about 90th hour for the prd-1 mutant. The time points 
to represent the growth limit at the stationary phase are around 52nd hour for WT and around 
108th hour for the prd-1 mutant.  
Figure 5.1 The standard growth curve in 1% glucose Vogel’s medium. The dashed lines showed the 
half/maximum growth to determine the harvesting time points for subsequent experiments. 
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5.3.2 The growth response to glucose concentration gradient 
The dry weights of mycelia grown in media with a gradient of glucose concentration 
were measured (Figure 5.2). I found that WT and the prd-1 mutant had parallel responses 
when glucose concentration decreased. The prd-1 mutant seems to be able to transform more 
glucose to mycelia even though the differences are not significant (P>0.05). The growth 
reached maximum when they were harvested at 36th hour with 0.25% and 0.125% glucose. 
Since the growth stopped when the glucose is used up, the data considered as half maximum 
growth cannot be analyzed.  
 
Figure 5.2 The maximum growth in Vogel’s media with a gradient of glucose concentration. 
Samples were collected at 50th hour (WT, green) and 108th hour (prd-1-, red). Means of dry weight ± 
SEM are shown. Data from three independent experiments were analyzed.  
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5.3.3 The growth response to amino acids  
Intriguingly, when different amino acids were supplied in the Vogel’s media with 1% 
glucose, different responses were seen (Figure 5.3).  
In WT, when NH4NO3 was present, extra glutamine and arginine had no effect for the 
growth limit nor growth rate, whereas leucine suppressed the growth dramatically. When 
amino acids were the only nitrogen resource, glutamine and leucine cannot be assimilated 
efficiently and leucine scarcely can be used for growth; arginine maintained the normal 
growth limit but decreased the growth rate. 
  As for the prd-1 mutant, when NH4NO3 was present, glutamine promoted the growth 
slightly whereas arginine inhibited the growth in both aspects; unlike WT, leucine generated 
no effect on either growth limit or growth rate. When NH4NO3 was absent, glutamine 
inhibited the growth limit but not growth rate; arginine inhibited the growth at both levels; 
leucine also inhibited the growth to the same extent as arginine.  
 The trends can be observed directly in Figure 5.4. The growth curves of both strains were 
simulated based on collected data. In the standard condition (NH4NO3), the curve of prd-1- 
can be considered as stretched in the X-axis and slightly elevated in the Y-axis compared to 
WT (portrayed in green). With glutamine in the medium, the growth curve of prd-1- can be 
generated from the curve of WT the same way as described in the standard condition. 
However, with arginine in the medium, the curve of prd-1- is suppressed in the Y-axis 
compared to WT. With leucine, the curve of prd-1- is dramatically elevated in the Y-axis 
compared to WT. These data demonstrate that the prd-1 mutant responds differently with 
arginine and leucine present in the medium.  
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Figure 5.3 The growth in Vogel’s media with 50mM amino acids. Samples of half maximum growth 
(darker left bars) were collected at 36th hour (WT, green, left panel) and 90th hour (prd-1-, red, right 
panel). Samples of maximum growth (brighter right bars) were collected at 50th hour (WT, green, left 
panel) and 108th hour (prd-1-, red, right panel). Means of dry weight ± SEM are shown. Data from 
three independent experiments were analyzed. 
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Figure 5.4 Simulated growth curves of WT (0-72h) and prd-1- (0-140h) strains in Vogel’s liquid 
media with 1% glucose and 50mM glutamine (a), arginine (b) and leucine (c). The curves were 
smooth fit lines of scatter plots generated by Microsoft Excel based on the data collected in Figure 
6.3 and Figure 6.1 
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5.4 Conclusion 
In this chapter, I attempted to examine whether the prd-1 mutant impacts nutrient sensing 
which could influence the growth pattern and the circadian rhythms. Dry weight of the 
mycelia harvested at two time points for each strain was measured based on the standard 
curves. 
In the media with a gradient of glucose concentration, the growth pattern of the prd-1 
mutant behaved the same as the wild type. This result suggests that the prd-1 gene does not 
function in the glucose-sensing pathway. The relocalization of PRD-1-GFP and the change 
of period under different abundances of glucose may be the downstream responses to the 
altered growth. 
In the media with different amino acids, the prd-1 mutant displayed distinct growth 
patterns to those of wild type. When NH4NO3 was present, both strains behaved alike with 
extra glutamine; however, they reacted conversely with extra arginine and leucine. When the 
amino acids are the sole nitrogen source, the wild type cannot utilize glutamine and leucine 
efficiently but does use arginine for the standard growth. The prd-1 mutant, intriguingly, 
showed a similar assimilation efficiency on all three amino acids regardless of faster growth 
rate with glutamine. 
These data suggest that the prd-1 mutation affects nutrient-sensing or metabolic 
pathways of N. crassa resulting in different growth responses. 
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Chapter 6  Discussion  
The prd-1 mutant was found to lengthen the period of the circadian rhythm and to reduce 
the growth rate. Most of the work on the circadian clock in Neurospora crassa has been 
conducted involving the frq gene which is considered as the core regulator in the circadian 
oscillator, but how the prd-1 mutant affects the circadian rhythm was poorly understood. 
When the FRQ-WCC oscillator is disabled, rhythms can still be observed, which suggests 
that a FRQ-less oscillator exists. The prd-1 mutant also disrupts the FRQ-less rhythm. 
Therefore, studying the function of the prd-1 gene helps us to understand the mechanism of 
circadian rhythm regulation. 
Although the prd-1 gene has been identified as a homologue of DEAD-box RNA 
helicases, there is still limited information to clarify in which biological processes the prd-1 
gene is involved. Building on previous research, in my project I tried to obtain a prd-1 knock-
out strain; I constructed strains expressing FLAG-tagged PRD-1 protein and assayed the 
rhythmicity of its expression; I performed co-IP to pull down the proteins binding to PRD-1 
and identified them by MS analysis; I examined the growth response of the prd-1 mutant to 
different glucose concentrations and amino acids; and I attempted to construct the C-terminus 
deleted prd-1 strain. The results of these various experiments outlined an approximate profile 
of the function of prd-1. 
6.1 Lethality of prd-1KO 
The failure to purify the prd-1KO homokaryon indicated that prd-1 is an essential gene 
for survival. The PRD-1 protein consists of 4 domains: N-terminus, DEAD/DEAH box 
domain, helicase domain and C-terminus. The absence of all four domains in the prd-1KO 
resulted in the lethality. However, more than one DEAD-box RNA helicase is expressed in 
the cell, especially FRH, one that is not essential but affects the circadian rhythm by binding 
to FRQ. The helicase activity of FRH is not required for its function in the circadian clock 
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(Cheng et al., 2005). This implies that the DEAD-box and the helicase domain may be 
dispensable and the N- or C-terminus has effects that may be crucial for the clock function. 
The C-terminus is the eye of storm as well because the point mutation is located in the C-
terminus and causes altered amino acid sequences of PRD-1 in the mutant. The failure to 
purify the C-terminus deleted prd-1 homokaryons demonstrated that the C-terminus is 
indispensable for the intact function of PRD-1 as expected. The N-terminus may also be 
important for the function of PRD-1 but the study of it is a lower priority since no evidence 
showed the N-terminus affects the circadian rhythm.  
 
6.2 Dose effect of the expression of prd-1 
In the prd-1 mutant, a small amount of wild-type prd-1 mRNA was detected76. The prd-
1KO heterokaryon possessed only a small proportion of wild-type nuclei under the stress of 
hygromycin selection (Figure 2.2). These data suggested that a small number of genomic 
copies of wild-type are sufficient for survival. Are they sufficient to maintain the circadian 
rhythm? The hypothesis is that a low expression level of prd-1 leads to the long period of the 
rhythm. In the prd-1 mutant, the expression of wild-type mRNA is very low since most of 
the pre-mRNA would be spliced aberrantly. The minimum amount of PRD-1 protein may 
need to be produced to maintain survival. The result of the Northern blot that the total 
expression of prd-1 mRNA in the mutant was much higher than that in wild type supported 
that (Figure 3.15). If the hypothesis is correct, normal expression level would lead to a wild-
type period and overexpression of prd-1 would cause a shorter period. In Chapter 3, I 
constructed several strains carrying more than one copy of the wild-type prd-1 gene in a 
single nucleus. The periods of these strains were various – longer or shorter than the wild 
type. In contrast to the hypothesis, the strain with ccg-1 promoter which was expected to 
have the highest expression level showed the longest period. Although some unknown factors 
(such as the expression efficiency of each copy of prd-1 in one nucleus and the potential 
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effects of the FLAG tag) may contribute, no clear association could be found between the 
period of the circadian rhythm and the abundance of PRD-1.  
 
6.3 Fluctuation of PRD-1-FLAG 
The circadian rhythmic expression of a gene reflects a close association with the 
circadian clock. I assayed the rhythmicity of the mRNA and protein of prd-1 in Chapter 3. 
Neither one fit into the pattern of a circadian rhythm. A fluctuation of PRD-1-FLAG was 
found from the samples in constant dark while the prd-1 mRNA did not fluctuate. The lack 
of correlation between the expression level of the prd-1 mRNA and PRD-1 protein suggested 
post-transcriptional regulation of the prd-1 gene. Once the mRNA is synthesized, it will be 
transported to the cytoplasm for translation. The accumulation of a protein is modulated by 
many factors in the processes. The efficiency of transportation and translation initiation 
determine the synthesis of the protein. The post-translational modifications such as 
phosphorylation, ubiquitination and acetylation determine the decay of the protein. Hence, 
further study is needed to understand the post-transcriptional regulation of the prd-1 gene. 
The samples for the assay of rhythmicity were collected every four hours and the 
expression levels were detected in vitro. Even though every effort was made to reduce the 
error during the experiment, the variation was still high among independent experiments. A 
proper reporter to demonstrate the expression levels of the prd-1 gene in vivo would be 
helpful to confirm these results.  
 
6.4 The role of PRD-1 in ribosome-associated biological processes 
The binding partners of PRD-1 provide direct clues for understanding its function. In 
Chapter 4, I performed co-IP and MS analysis to discover the proteins interacting with PRD-
1. Ribosomal proteins from both subunits were found in the list. The results indicate that 
PRD-1 plays a role in ribosome-associated biological processes. 
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Taking the localization into account, PRD-1 may have two potential functions. In the 
nucleus PRD-1 may be a key component or a scaffold of ribosome biogenesis. PRD-1may 
be a component in both small and large ribosome subunits. Due to RNA helicase activity, 
PRD-1 may also bind with rRNAs which are the skeleton to form a ribosome. In the 
cytoplasm, PRD-1 may be an essential element in the translation machinery. Small and large 
subunits assemble when translation initiation factors bind to mRNAs. In this huge complex, 
ribosomal proteins and PRD-1 may cooperate to accomplish the translation. It is reported that 
PRD-1 is a nuclear protein so that the first role may be closer to the truth. However, it is also 
reported that PRD-1 was found in the cytoplasm when the hyphae were starved. Moreover, 
during protein extraction, the cells were homogenized and proteins from either the nucleus 
or the cytoplasm may seize the chance to bind onto PRD-1. Thus, I cannot draw conclusions 
about the functions of PRD-1 until more evidence is discovered. But at least, it is convincing 
that the PRD-1 protein is able to physically bind to ribosomal proteins. 
DEAD-box RNA helicases are extensively implicated in ribosome biogenesis. 19 
putative DEAD-box RNA helicases were considered to function in ribosome synthesis in 
yeast (Martin et al., 2013). In human cells, it was experimentally supported that several 
DEAD-box RNA helicases such as DDX3, DDX5, DDX10, DDX24, DDX47 were involved 
in ribosome biogenesis pathways (Linder and Jankowsky, 2011). PRD-1 is a DEAD-box 
RNA helicase and is homologous to DBP2 in yeast, DDX5 and DDX17 in mammals 
(Adhvaryu et al., 2016, Emerson et al., 2015). DBP2 has been implicated in ribosome 
synthesis and mRNA metabolism (Bond et al., 2001). DDX5 localizes to nuclei and nucleoli 
and is closely related to DDX17. The two helicases can form a heterodimer which is 
important in processing of the 32S rRNA precursor and 5.8S rRNA (Martin et al., 2013). 
Since the ribosome biogenesis pathway is highly conserved in eukaryotes, PRD-1 probably 
functions in ribosome biogenesis as well in Neurospora. 
The heterokaryotic C-terminus deleted prd-1-flag strain could help us confirm the result 
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as well. In the heterokaryon, both wild type and partially deleted genes are expressed. If the 
C-terminus is the region that binds to ribosomal proteins, the list of binding partners to the 
truncated protein should be shortened or altered. The missing candidates between lists would 
give us information about the binding proteins of C-terminus, which may lead us to the 
function of PRD-1. If the same proteins showed up, which means DEAD-box domain and 
the helicase domain may be the binding site, the C-terminus probably is important for 
regulating the activity of PRD-1. 
PRD-1 may also interact with the rRNAs. RNA IP-sequencing may be required to 
identify the composition of the RNAs and give more information on the function of PRD-1. 
 
6.5 The potential role of PRD-1 in nutrient sensing  
Evidence has been found to associate FLO with the nutrient sensing pathway as 
mentioned in Chapter 5. Growth experiments were conducted to assay the growth responses 
of the prd-1 mutant to different media. The prd-1 mutant behaved significantly differently 
from the wild type when arginine or leucine was present.  
Arginine, which is the main nitrogen stock in the vacuole of Neurospora, inhibited the 
growth of the mutant. When excessive amino acids or nitrogen are absorbed in the cell, the 
extra will be converted to arginine or ornithine and stored in the vacuole (Davis, 1986). When 
the amino acids in the cytosol are depleted, the stored arginine will be released into the 
cytosol. The growth of the prd-1 mutant was inhibited by arginine in the media with and 
without ammonium nitrate, implying that the mutant could not utilize arginine efficiently for 
growth, or the mutant altered the regulation pathway so that the arginine functioned as a 
growth repressor instead of an enhancer. 
Leucine, which stimulates TOR activity in mammals and yeast (Stracka et al., 2014), is 
not a preferred nitrogen resource in Neurospora. In contrast to glutamine, which is also a 
signal to stimulate the TOR pathway and promote growth, leucine dramatically inhibits the 
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growth of Neurospora. By itself it could scarcely be assimilated by Neurospora as shown in 
Figure 5.3. Intriguingly, the prd-1 mutant seems to be immune from the impacts of leucine. 
The additional leucine no longer suppressed the growth of the mutant. Leucine supplied as 
the only nitrogen source in the media could be utilized as efficiently as glutamine and arginine. 
These results suggest that in the prd-1 mutant, the nutrient sensing and metabolic pathways 
are dramatically altered. The inhibitory activity of leucine may be erased or bypassed. The 
catabolism of leucine somehow is reactivated even if it is barely possible that a novel 
catabolic pathway is created in the mutant. Unknown links among leucine, prd-1, the TOR 
pathway and other metabolic pathways are waiting to be discovered. 
 
6.6 Prd-1 and the regulation of the circadian rhythm 
So far I have discovered that the prd-1 gene is associated with ribosome-related 
processes and metabolic pathways of arginine and leucine, indirectly associated with the 
circadian clock and that the intact prd-1 gene especially the C-terminus is essential for its 
function relating to viability. However, it is still poorly understood why the circadian rhythm 
is altered in the prd-1 mutant and some prd-1-flag transformants.  
Recently, crosstalk between metabolism and the circadian clock in mammals has been 
addressed more frequently. It has been reviewed that disruption of clock genes results in 
metabolic dysregulation (Huang et al., 2011). Some studies hint that amino acid metabolism 
may participate in the regulation of the temporal organization of feeding and the circadian 
clock. Studies have demonstrated that the cellular nutrient status can be relayed to the 
circadian clock by various nutrient sensors (Huang et al., 2011). In mammals, the mTOR 
pathway is a prime target to make a breakthrough to understand the crosstalk. The mTOR in 
the central nervous system (CNS) is present in the arcuate nucleus neurons modulating food 
intake (Cota et al., 2006). The expression of mTOR is activated by light within pacemaker 
neurons of the SCN (Cao et al., 2010). The light induction of the Period gene within the SCN 
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is altered when mTOR is inhibited (Cao et al., 2010).  
My first hypothesis is that the alteration of the phenotype in the mutant is a consequence 
of effects on TOR pathway caused by the low expression of the wild-type prd-1 protein. From 
the MS analysis, ribosomal protein S6 is at the top of the candidate list. The S6 kinase in 
mammals or the homologue Sch9 in yeast is a substrate that could be phosphorylated by TOR 
complex 1 (Loewith and Hall, 2011). The activated S6 kinase phosphorylates the ribosomal 
protein S6 and stimulates anabolism which promotes growth. Since PRD-1 could physically 
bind to ribosomal protein S6, the prd-1 gene may play a crucial role in regulation downstream 
of the TOR pathway. Incorporating the association between the TOR pathway and the 
circadian clock, it is possible that the down-regulated TOR pathway in the prd-1 mutant 
lengthens the period and alters the period under different glucose concentrations. The dose 
effect could be included in this model. To verify this hypothesis, the phenotype of an 
inducible prd-1 knock-down strain will be informative. 
In spite of some clues that the TOR pathway may affect the circadian clock, it is still 
unknown whether the impact of downstream regulation of the TOR pathway caused by the 
mutated PRD-1 indeed causes the change of the circadian rhythm. My second hypothesis is 
that the limited amount of PRD-1 in the mutant merely induces the slow growth rate due to 
its putative function in ribosome biogenesis and translation regulation; the circadian clock is 
not directly impacted by the low expression of the wild-type PRD-1. Since the C-terminus is 
essential for survival, the mutated PRD-1 protein cannot function normally whereas the wild-
type PRD-1 functions normally and only the rate of growth is decreased. In this situation, the 
function of the mutated PRD-1 protein is the key to understand why the period is changed in 
the mutant. If the mutated C-terminus is dysfunctional, my first hypothesis will be the most 
possible explanation to the altered phenotype. If the mutated PRD-1 does influence the 
biological processes related to ribosomal protein S6, then the interaction between the TOR 
pathway and the mutated protein need to be verified. In both hypotheses, investigating the 
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mechanism of the regulation of the circadian clock by the TOR pathway is pivotal to build 
up the models. 
My third hypothesis is that the mutated PRD-1 possesses ‘neomorph functions’ which 
might be the origin of the period change. The mutated PRD-1 may interact with something 
else that could directly influence the circadian clock. In this case, every mutated protein 
produced from the variety of mis-spliced mRNAs of prd-1 needs to be inspected for its 
potential effects on the circadian clock. 
 
6.7 Future Work and Perspective 
In this thesis, I discovered that the expression of the prd-1 gene is not circadianly 
rhythmic; that the C-terminus of the prd-1 gene is crucial for its function; that the binding 
partners of the protein product of the prd-1 gene are ribosomal proteins and that the strain 
with the mutated prd-1 gene responds differently to arginine and leucine. However, more 
experimental work needs to be carried out to confirm the results or to test the hypotheses.  
In Chapter 3, only one strain which behaves most closely to the wild type was used for 
the time-series experiments to investigate the rhythmicity of the prd-1 gene. The strain (#588) 
carries wild-type prd-1 genes at both the native locus and his-3 locus, which might affect the 
circadian rhythm. In the future, the prd-1+-flag KI strain would be better for assaying the 
rhythmicity of prd-1 expression to confirm the results.  
To test the hypothesis that the prd-1 gene has a dose effect on the circadian rhythm and 
low expression level of PRD-1 causes the period alteration, I propose to construct an 
inducible prd-1 knock-down strain since the growth might be impaired by the knock-down. 
The expression level of prd-1 can be regulated by the inducible promoter and the period 
might vary with different levels of prd-1 expression.  
To verify the association between the TOR pathway and the circadian rhythm, the 
phenotype of knockout strains of ribosomal protein S6 and S6 kinases may provide us with 
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some clues, since the ribosomal protein S6 kinases are major downstream effectors of the 
TOR complex (Loewith and Hall, 2011) and PRD-1 can bind to ribosomal protein S6. 
In Chapter 4, the binding partners of PRD-1 were found to be ribosomal proteins. To 
confirm the results, some other techniques may be applied such as Bioluminescence / 
Fluorescence resonance energy transfer (BRET / FRET), reciprocal Co-IP, or Luciferase 
Complementary Imaging System. Other strains expressing PRD-1-FLAG could be used for 
Co-IP/MS to double-check the results. Taking the RNA helicase activity into account, RNA-
IP/RNA-seq could be conducted to assay what RNA is binding to PRD-1. If the PRD-1 
protein binds to rRNA, it would be more convincing that PRD-1 plays a key role on ribosome 
assembly.  
In Chapter 5, the abnormal growth response to arginine and leucine suggested an 
interaction between amino acid sensing (specifically the TOR pathway) and the prd-1 gene. 
To confirm the results, different concentrations of amino acids could be added to the media 
and harvesting time may be optimized from medium to medium so that the real maximum 
growth could be obtained. To better understand the relationship between PRD-1 and the TOR 
pathway, growth experiments of strains possessing deficient TOR pathway could be carried 
out under the same conditions. If the deficient strains react similarly to the prd-1 mutant, I 
would be more confident to conclude that the PRD-1 protein can affect the amino acid 
sensing pathway. 
In Chapter 2, I demonstrated that the C-terminal deletion of prd-1 is lethal, which 
suggests that the C-terminus of PRD-1 is indispensable for its function. The results of Co-
IP/MS of the heterokaryon expressing truncated PRD-1-FLAG might help us to understand 
the reason for the lethality. The proteins missing from the list could indicate the impact of C-
terminal deletion via impaired binding capability, which might inform us about the function 
of PRD-1.  
Moreover, the hypothesis that mutated PRD-1 proteins have null function has not been 
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tested. The phenotypes of strains expressing each mutated PRD-1 protein and the binding 
partners of each need to be examined. To achieve this goal, each alternatively spliced mRNA 
sequence that leads to a mutated PRD-1 protein should be knocked into the prd-1 locus. 
In my view, the current mainstream model of the circadian oscillator is too succinct to 
be true. It has been verified that circadian rhythms could be entrained by many zeitgebers, 
for instance, light, temperature and food availability. In mammals, “different zeitgebers may 
exert differing effects on circadian entrainment in the brain and peripheral tissues, leading to 
distinct effects on phase and amplitude of gene oscillation within these locales” (Huang et 
al., 2011), and the trend is for more research to be carried out on the circadian clock. In 
Neurospora, the FRQ-WCC oscillator is well characterized and is tightly interacting with 
light entrainment. However, the appearance of the FRQ-less rhythm indicates that there must 
be more than the FRQ-WCC oscillator. The effect of nutrition on the output of the circadian 
clock has been noticed decades ago but not an effect on the oscillating mechanism. The study 
of the prd-1 gene gives direct evidence linking the nutrient sensing pathway to the circadian 
clock, which could be a key to open the blackbox of the FLO. 
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Appendices  
Appendix A: Genotype of the Strains  
 
#1     bd (mat a) 
#4    bd (mat A) 
#26    csp-1; chol-1 bd (mat a) 
#80    csp-1; chol-1 bd ; frq10 (mat a) 
#170   prd-1; bd (mat A) 
#260   csp-1; prd-1; chol-1 bd (mat a) 
#274         csp-1 his-3; chol-1 (mat a) 
#310   csp-1 his-3; prd-1; chol-1 bd (mat a) 
#438   rid^delta ::hph+ his-3::lpl^delta (5192-6040) ::hph+::tk+ ::flag-pcna; inl- 
#444   csp-1 his-3+::Pccg-1::NCU05950+-flag; NCU05950KO; chol-1 bd (mat a) 
#471-476*  csp-1 his-3+:: Pccg-1::prd-1+-gfp ; chol-1 bd    [ccg-prd-1-flag] 
#477-479*  csp-1 his-3+:: Pprd-1::prd-1+-flag; chol-1 bd   [native-prd-1-flag] 
#480   csp-1 his-3+:: Pccg-1::prd-1+-gfp ; prd-1; chol-1 bd (mat a) 
#484-486*  csp-1 his-3+:: Pprd-1::prd-1+-flag; chol-1 bd     [native-prd-1-flag] 
#490   csp-1 his-3+::Pprd-1::prd-1+ ; prd-1; chol-1 bd (mat a) 
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#493-495*  csp-1 his-3+:: Pccg-1::prd-1+-gfp ; chol-1 bd    [ccg-prd-1-flag] 
#505-507*  csp-1 his-3+:: Pccg-1::prd-1+-gfp ; chol-1 bd    [ccg-prd-1-flag] 
#518 heterokaryon of [ (csp-1 his-3+::Pccg-1:: rfp-vam-3; chol-1 bd), (csp-1 his-
3+::Pccg-1:: NCU05950-gfp; chol-1 bd; NCU05950KO)] 
#519*   csp-1 his-3+:: Pprd-1::prd-1+-flag; chol-1 bd   [native-prd-1-flag] 
#520*   csp-1 his-3+:: Pprd-1::prd-1+-flag; chol-1 bd   [native-prd-1-flag] 
#567    his-3; Δmus-51:: bar+ (mat A) 
#586   csp-1 his-3+::Pccg-1::prd-1+-flag ; chol-1 bd (mat a) 
#587   csp-1 his-3+::Pccg-1::prd-1+-flag; chol-1 bd; frq10 (mat a) 
#588   csp-1 his-3+::Pprd-1::prd-1+-flag ; chol-1 bd (mat a) 
#589   csp-1 his-3+::Pprd-1::prd-1+-flag ; prd-1; chol-1 bd (mat a) 
 
*: Strains that were mis-labeled in the stock. Old names are in the spare parentheses. 
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Appendix B: Recipes  
Trace element solution 
In 95 ml distilled water, dissolve successively with stirring, at room temperature: 
5 g Citric acid.1H2O  
5 g ZnSO4.7H2O  
1 g Fe(NH4)2(SO4)2.6H2O 
0.25 g CuSO4.5H2O  
0.05 g MnSO4.1H2O  
0.05 g H3BO3 (anhydrous)  
0.05 g Na2MoO4.2H2O  
Store in a stoppered bottle at room temperature, with 1 ml chloroform added as preservative.  
 
Biotin stock solution: 
Dissolve 5 mg biotin in 50 ml water or 50% ethanol. Tube 2.5 ml aliquots and store at -20°C. 
 
50× Vogel’s salt  
755 ml water  
125 g Na3 citrate.2H2O  
250 g KH2PO4  
100 g NH4NO3  
10 g MgSO4.7 H2O  
5 g CaCl2. 2H2O (dissolved) 
5 ml trace element solution  
2.5 ml biotin stock solution  
Dissolve constituents successively. Moderate heating is useful in speeding solution of the 
citrate and phosphate. Dissolve the calcium chloride separately in 20 ml water and add the 
solution slowly. Add about 5 ml chloroform as preservative and store the solution at room 
temperature. Dilute with water to 1× working solution to make Vogel’s medium. 
 
SC medium 
For 2× stock, dissolve the following successively in 3 liters water: 
6.0 g KNO3  
4.2 g K2HPO4 (anhydrous) (or K2HPO4.7 H2O) (5.49 g) 
3.0 g KH2PO4 (anhydrous)  
112 
3.0 g MgSO4.7H2O  
0.6 g NaCl  
0.6 g CaCl2.2H2O (dissolved separately)  
0.3 ml biotin stock solution  
0.6 ml trace element stock solution  
Add 2 ml chloroform as preservative and store at 4°C.  
 
12% SDS-PAGE 
Separating gel: 
Total volume  5.0 ml 
Water     2.17 ml 
1.5M Tris pH 8.8 1.25 ml 
10% SDS   0.05 ml  
40% acrylamide  1.50 ml 
Add just before pouring: 
10% APS   25 µl  
TEMED   2.5 µl  
 
Stacking gel: 
Total volume  2.5 ml   
Water    1.55 ml  
0.5 M Tris pH 6.8 647 µl   
10% SDS   25.9 µl   
40% acrylamide  259 µl   
0.4%Bromphenol  
blue stock 2.5 µl  
Add just before pouring: 
10% APS   12.9 µl  
TEMED   2.59 µl   
 
Fill up space above separating gel with stacking gel and insert comb to correct depth. Allow 
at least 30 min to polymerize. 
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Appendix C: Primer Information 
 
native-prd-1 up-F (Not I): 
AAGAATGCGGCCGCCTATAGAATGTGGTCAAGATTACAGAT 
native-prd-1 up-R (Xba I):  
ACGTCTAGAGACAAGAACCAAACGACACGCGTGAAG 
PacI-NCU07839-3503-R (PacI(3xFLAG+7839)):  
CCTTAATTAA CCACCGGCGGTTGTTAAGCGGA  
SpeI-NCU07839-1040-F (SpeI(3xFLAG+7839)):        
GGACTAGT ATGTCCGGATCTTACGGCGGC 
rc 5r prd-1KO: GGTTCTTGTCTCTAGACGTC 
rc 3f prd-1KO: CCTGTAGATGAGACTTTCCG 
NCU07839-3136-F (Primer-F11): CTGCCATTACTTTCTTCACCACTGACA 
pBM61-1: ATTCAGACCCCATTAGCCGTCCACGCC 
His3-F1: TAGGTGGGAACGCTTGTATTGC 
His3-R2: TTCAGGCTATTGAGGACGAGGTTC 
NCU07839-1423-F: GAACTGGGACATGAGCGCTCTTCCC 
NCU07839-1636-R: AGGGAAACCCTGAGCCTTGACCTCG 
NCU07839-1662-F: GCTGGCCCATGGCCCTTTCTGGT 
NCU07839-3161+Gly-R: TCCGCCGCCTCCGCCGTCAGTGGTGAAGAAAGTAAT 
NCU07839-3161+Gly-F: ATTACTTTCTTCACCACTGACGGCGGAGGCGGCGGA  
Flag+T trpC-R: 
GAGGTAATCCTTCTTTCTAGAGGATCCTCACTACTTGTCATCGTCATCCTTGT
AGTCG 
Flag+T trpC-F: 
CGACTACAAGGATGACGATGACAAGTAGTGAGGATCCTCTAGAAAGAAGGA
114 
TTACCTC   
P trpC+downstreamNCU07839-R: 
TTAGACAGCGAGCTAGGACAGAGACCTACCGTCGACAGAAGATGATATTGA
AGG  
P trpC+downstreamNCU07839-F:  
CCTTCAATATCATCTTCTGTCGACGGTAGGTCTCTGTCCTAGCTCGCTGTCTAA 
Downstream NCU07839-R: TACGTAACCTTAGGGTCTCTACCGGTTCTATCCC 
NCU07839-1600-F: CTACGTTATGGACGAGGTCAAGGCTC 
NCU07839-2181-F: TCATCCAGGTCAACATCGGTTCCAT 
NCU07839-2259-R: GACTCGGAAACAACCTCGACGATCT 
NCU07839-2661-F: CGTGTCGACTTGGTCTATCTGAGTG 
NCU07839-2733-R: GGGCGTAGCATAGTCCACTGTTTCT 
T trpC-F1: ACCGTTGATCTGCTTGATCTCGTCTC 
T trpC-R1: GCATTGACTGCAACCTAGTAACGCC 
Hph-F1: CGAGTACTTCTACACAGCCATCGGT 
Hph-R1: GGCAATTTCGATGATGCAGCTTGGG 
Hph-F2: GTCGTCCATCACAGTTTGCCAGTGA 
Hph-R2: GGACCGCAAGGAATCGGTCAATACA 
Hph-F3: CCCTCCTACATCGAAGCTGAAAGCA 
Hph-R3: ATGAAAAAGCCTGAACTCACCGCGA 
Downstream NCU07839-F1: AATGAGCAACCTCCAACCACGTTTTG 
Downstream NCU07839-R1: TGGCCATTCAGCAAAATCAACACCG 
Downstream NCU07839-F2: CCGGGTTAAAAGAAGTAATGCGACCC 
Downstream NCU07839-R2: CTTATAGGCGAACGGGCAAATCGTT 
Downstream NCU07839-R3: ACGTAACCTTAGGGTCTCTACCGGT 
NCU07839-3161+ PacI-R: GCCCTTAATTAAGTCAGTGGTGAAGAAAGTAAT 
115 
PtrpC+NotI-R: GACCTGCGGCCGCACCGTCGACAGAAGATGATATTGAAGG 
NotI+downstreamNCU07839-F: 
ACGGTGCGGCCGCAGGTCTCTGTCCTAGCTCGCTGTCTAA 
Flag-R: TCACTACTTGTCATCGTCATCCTTG 
KpnI-downstream7839-F: TCGACGGTGGTACCAGGTCTCTGTCCTAGCTCGCTGTCT 
KpnI-PtrpC-R: AGAGACCTGGTACCACCGTCGACAGAAGATGATATTGAA 
SbfI-NCU07839-1600-F: 
ATAGAGCCTGCAGGCTACGTTATGGACGAGGTCAAGGCTC 
SbfI-pJET-R: TAACGTAGCCTGCAGGCCTACAATATTCTCAGCTGCCATGG 
NotI-downstream7839-R: 
ATAGTTCAGCGGCCGCTACGTAACCTTAGGGTCTCTACCGG 
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Appendix D: Sequences 
 
Ccg-1 promoter:  
GCTAGAAGGAGCAGTCCATCTGCGTGAATCACGAGAGAATCAGCTACTTTGAAT
CGATGGATGCAGCTACCAGAAGTCACTCAGTTCGTTCAAAGCCACATCACTGGG
CACTTCCATTGGGACAGGCATTGATCGGACGAGACCGACTTCTGGCCGCTTTCA
ACAGCCACATTATATCCATGTCACGGCTACGCGTCGGCCTTCGGTAACAGAAAA
GCACACAGACAGCGATTGTGACATGGATTCGGGCAAAGCATTGGTGGTCGCACC
AGGTCATCCTGAGTGTGCAGTGGCTGCTATTCAGATTTCATCTAACTGCGGGAGA
GGGGTTCAAAGGGGCGTGACGTCACAGACAACGGGTGAAGGACGAAGATTGC
CTCACTTCTTTGCTAGCAATTTGCCTGCAAAGAAGGCGCACATGACAAGCAAAC
AACTGGGAAACCACTATTGAATACCCACAATGCAAAGCTCGGAAGGTACGTCTT
GATTGCAGTGTGTCGAGTGTCAAAAAAGAAGCAAGTGTTCATGCAAGCCAAAA
TTGGCACCTCCTCCACTTCTCCGAGTGCCCCACCCGAACCTCCAGGCGAGATGG
CCGGAACATACCATCCGCGTTGGGATTATGACGTATCTCCTTCTTCTTCACATGAT
TCCATCCCGTTGTTGCTTGTTTGCGAGCTGTGACGGGAGATCGTAGATGCCACTT
CGGGCCAGGCAGGCAGTGCAGGCAGCCAGGAACACAAGCTTCCAACTTGGTCA
TCTCGATTGCCGATTAAGGGAACCAAATGCCTATATAAGACTGTCCTCCCACCTC
CCCAATACCATTCTTTTCTTCTTCCATCATCAGCCAACAAAGCAATCACATCTTCA
CTACTTCAAATCAACACAACACTCAAACCACTTTCACAACCCCTCACATCAACC
AAATCTAG 
 
Prd-1 promoter: 
GCGGCCGCCTATAGAATGTGGTCAAGATTACAGATTCTCTTTTCCGTTCCCTGAC
AGCTGAGGTGAGCGACGACGGATGATTGCCCAACAACCGCGACGCGCAGCAAA
GACTGCCAAGCATAATCCGCCAGTGAAGCAAGAACGAGAACCCTTCTGGCAAA
117 
GCGGAGTCGGTGAACCAGGTGACGCCAATTCCCGCAAAGGTGGACTTCTGCCT
GATTGATAAGGCCACACATGCCTTATCGGCGCTTTATCTGTGCTTATCTGTGCTTG
TCAACAGTGAAAGAATGCAGGCCCGCCAAGTGTTGCCAGTCGGGTCCAGTTTTT
TTTTTCTCTGGTGCCAGACCGCCCCTACATGGAAGTCTGGGGGACAGGTACGGC
AATGCCCGGTCCCCTCAAATCCGCCTTCGCTGTAACGACTGCAGTGAACTGAAG
GGAAGGGAAGAAAAAAAAAATATTTTTCTGGGGCACTTGCACGCAAGGGACGC
GTTGCGCCTTCCGCCTCCAACAAAAAGAAAGACTTTTTCTTCCCGCTTGGAGGC
GAGTCGGGTCTGGCACAGGATCCGCATCTCACATCCACTAGCACTGCACAGCGG
AACCCACCAATCCTCCATCGACATCTCCCTTTGGTCAGGTTCTTTTCCCATACTAA
CCTTACGTGACGGGTCCTTGTCCAGTGCCCCCAGAGTTTTTTTCGTTTCGACTTC
CGTCCAGAAAAACTTGCACTTCACCCTTCGCAGCAGCCCTTTTCTTCCTTCCTTC
CACCCACCCTCCATCTCCAATATCCCTTCCCGCCTACTTCTTGCGATTCTGCAAGA
TTCTTCATCCGCGATCCTTCTTTAACCAGTCGGACTGCTTACTTGTAACCACTTCA
CGCGTGTCGTTTGGTTCTTGTCTCTAGACGTCTGTCTTTTCCGACGTCTTCTTTTC
CCGACAATCGATACCCTTGCGCCTCTAGGCCTTGTTTGCTCGTCGTTTCGGTCTA
CCCTTCAGCAACCCCAATAACAACCGATCTTCAATTTTCAACCTTTTCTTAAACA
ACCAGCAAAC 
 
10X Gly:  
GGCGGAGGCGGCGGAGGCGGAGGCGGAGGC 
 
3X FLAG: 
GACTACAAAGACCATGACGGTGATTATAAAGATCATGACATCGACTACAAGGAT
GACGATGACAAG 
 
GFP: 
118 
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGA
GCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGG
GCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGC
TGCCCGTGCCCTGGCCCACCCTCGTGACCACCTTCACCTACGGCGTGCAGTGCT
TCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGC
CCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTAC
AAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGA
GCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGG
AGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACG
GCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAG
CTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTG
CCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGA
GAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCT
CGGCATGGACGAGCTGTACAAGTAA 
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Prd-1 CDS with intron: 
ATGTCCGGATCTTACGGCGGCGGCGGCTACGGTGGCCGCGGTGGCGGTGGTGGT
GGATATTCTAACGGGTACGATCGCAATGGCGGCGGCTACTCTAACAACTACTCCT
CACACGGGTATGATGTTTTAGCGCGAACCTGCTCATTTCCTCTCTCTCTCTCTCTC
TCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTTTGCATTT
CAAGATCAAATTGCTAACATCTGGTTCAACAGTGGCTCGAATGGCTACGGAGGC
GGCGGCGGAGGATATGGCGGCGGTGGTGGTGGCTACGGAGGCGGCGGCTACGG
TGGTGGTGGCGGCGGTGATAGGATGTCTGCTCTCGGTGCTGGTCTGCAGAAGCA
GAACTGGGACATGAGCGCTCTTCCCAAGTTCGAGAAGTCCTTCTACCAAGAGCA
TCCTAGCGTCGCCAACCGATCTCCTGCTGAGGTCGACAAGTTCCGCGCAGACCA
CTCCATTGCCGTCTTCGGTAACAACGTTCCCAAGCCTGTCGAGACCTTCGACGA
GGCTGGTTTCCCTCGCTACGTTATGGACGAGGTCAAGGCTCAGGGTTTCCCTGC
TCCTACTGCCATTCAGTCGCAGGGCTGGCCCATGGCCCTTTCTGGTCGCGATGTC
GTCGGTATTGCCGAGACCGGTTCCGGAAAGACGCTCACCTACTGCCTTCCCGCC
ATCGTTCACATCAACGCTCAGCCTCTCCTCGCTCCCGGCGATGGCCCTATCGTCC
TCATCCTCGCCCCTACCCGTGAGTTGGCTGTCCAGATTCAGCAAGAAATCTCCAA
GTTCGGCAAGTCGTCCCGCATTCGCAACACCTGCGTCTACGGTGGTGTCCCCAA
GGGTCCCCAGATTCGCGATCTTTCCAGGGGAGTCGAGGTCTGTATCGCCACCCC
CGGCCGTTTGATCGATATGCTCGAGTCTGGCAAGACCAACCTCCGTCGTGTCAC
CTACCTTGTCCTCGATGAGGCTGATCGCATGTTGGACATGGGTTTCGAGCCCCAA
ATTCGCAAGATCATCGGCCAGATTCGCCCTGATCGTCAGACTCTCATGTGGTCTG
CTACCTGGCCCAAGGAGGTCCGCAACTTGGCCGCCGACTTCTTGACCGACTTCA
TCCAGGTCAACATCGGTTCCATGGATTTGGCTGCCAACCACCGTATCACCCAGAT
CGTCGAGGTTGTTTCCGAGTCCGAGAAGCGTGATCGCATGATCAAGCATCTTGA
GAAGATTATGGAGGGCCGCGAGAACCAGAACAAGATCCTCATCTTCACCGGCAC
CAAGCGTGTCGCCGACGACATCACCCGCTTCCTCCGCCAGGACGGCTGGCCCGC
120 
TCTTTCCATCCACGGCGACAAGCAACAGAACGAGCGTGACTGGGTTTTGGACC
AGTTCAAGACTGGCAAGAGCCCTATCATGGTTGCCACCGACGTGGCTTCTCGTG
GTATCGGTATGTATCCATCTTACCCCTCCGCCCTGCCCAAACCCCTCCCCCCTTCT
TCTCTCCCCCATCTCAGGCGACTTCCAGCATACGTACGTGCTTGTGCTTTACTCTT
ATGTCTAGGGGCTCTCTTGATTGCGCGAACTTGCCTGACCTCGTGTCGACTTGGT
CTATCTGAGTGGAGTCTTGGGTTCGTGACGTAGCAGAAACAGTGGACTATGCTA
CGCCCGCGTGATTCTTCAATTGTACCTTTTTATCCCAGTTGTGGTACAAGCGAGG
AGTAGGCATTTCTTGATTCCCGTCAAGCTTGTCTCCAAGATTCCCAAGGGGATTT
GCATGCATGGCCCAAGGATCTCTGGAACCTTGGATCCCAACCCGGCATATTTTTC
GCAATGGACAGCCCACCTGCCAAGGAGAGAAGTACTACCAGAGGATCACAGAA
CATACCTAGATATTCGTGTTCTCCGTCCGTTCTGGAATGTCGTTATTCCAAACCCT
GCTATTGCTAACCACGGTCCTTTAAAAAAAGATGTGCGCAACATTACTCACGTGC
TCAACTATGACTACCCCAACAACTCCGAGGATTACATCCATCGTATCGGCCGAAC
TGGTCGTGCCGGTGCGAAGGGTACTGCCATTACTTTCTTCACCACTGACAGTAA
GTGTCACCTGAATCTGCCCATCCTTAGCCGAACGAAATTCTAATGTTATCTCTCCA
CAGACTCCAAGCAGGCTCGTGAGCTCGTCGGTGTGCTTCAAGAAGCTAAGCAG
CAGATTGACCCTAGACTTGCCGAGATGGCTCGCTACAGTGGTGGTGGAGGTGGC
CGCTTCGGTGGCTATCGCGGCCGTGGCGGCGGTGGATGGCGCGGTGGTAAGTCA
TTTTCACGCAGGTGAATTTGGCAGTTCCAATCCTAATAACCCTCATTAGGCCGTG
GCGGCGGTGGTGGCGGCGGCTCCGTCGGTGGTGCTAATGCTCT 
 
PtrpC-hph-TtrpC: 
ACCGTCGACAGAAGATGATATTGAAGGAGCACTTTTTGGGCTTGGCTGGAGCTA
GTGGAGGTCAACAATGAATGCCTATTTTGGTTTAGTCGTCCAGGCGGTGAGCAC
AAAATTTGTGTCGTTTGACAAGATGGTTCATTTAGGCAACTGGTCAGATCAGCCC
CACTTGTAGCAGTAGCGGCGGCGCTCGAAGTGTGACTCTTATTAGCAGACAGGA
121 
ACGAGGACATTATTATCATCTGCTGCTTGGTGCACGATAACTTGGTGCGTTTGTC
AAGCAAGGTAAGTGAACGACCCGGTCATACCTTCTTAAGTTCGCCCTTCCTCCCT
TTATTTCAGATTCAATCTGACTTACCTATTCTACCCAAGCATCGATATGAAAAAGC
CTGAACTCACCGCGACGTCTGTCGAGAAGTTTCTGATCGAAAAGTTCGACAGCG
TCTCCGACCTGATGCAGCTCTCGGAGGGCGAAGAATCTCGTGCTTTCAGCTTCG
ATGTAGGAGGGCGTGGATATGTCCTGCGGGTAAATAGCTGCGCCGATGGTTTCTA
CAAAGATCGTTATGTTTATCGGCACTTTGCATCGGCCGCGCTCCCGATTCCGGAA
GTGCTTGACATTGGGGAATTCAGCGAGAGCCTGACCTATTGCATCTCCCGCCGTG
CACAGGGTGTCACGTTGCAAGACCTGCCTGAAACCGAACTGCCCGCTGTTCTGC
AGCCGGTCGCGGAGGCCATGGATGCGATCGCTGCGGCCGATCTTAGCCAGACGA
GCGGGTTCGGCCCATTCGGACCGCAAGGAATCGGTCAATACACTACATGGCGTG
ATTTCATATGCGCGATTGCTGATCCCCATGTGTATCACTGGCAAACTGTGATGGAC
GACACCGTCAGTGCGTCCGTCGCGCAGGCTCTCGATGAGCTGATGCTTTGGGCC
GAGGACTGCCCCGAAGTCCGGCACCTCGTGCACGCGGATTTCGGCTCCAACAAT
GTCCTGACGGACAATGGCCGCATAACAGCGGTCATTGACTGGAGCGAGGCGATG
TTCGGGGATTCCCAATACGAGGTCGCCAACATCTTCTTCTGGAGGCCGTGGTTG
GCTTGTATGGAGCAGCAGACGCGCTACTTCGAGCGGAGGCATCCGGAGCTTGCA
GGATCGCCGCGGCTCCGGGCGTATATGCTCCGCATTGGTCTTGACCAACTCTATC
AGAGCTTGGTTGACGGCAATTTCGATGATGCAGCTTGGGCGCAGGGTCGATGCG
ACGCAATCGTCCGATCCGGAGCCGGGACTGTCGGGCGTACACAAATCGCCCGCA
GAAGCGCGGCCGTCTGGACCGATGGCTGTGTAGAAGTACTCGCCGATAGTGGAA
ACCGACGCCCCAGCACTCGTCCGAGGGCAAAGGAATAGAGTAGATGCCGACCG
GGATCCACTTAACGTTACTGAAATCATCAAACAGCTTGACGAATCTGGATATAAG
ATCGTTGGTGTCGATGTCAGCTCCGGAGTTGAGACAAATGGTGTTCAGGATCTC
GATAAGATACGTTCATTTGTCCAAGCAGCAAAGAGTGCCTTCTAGTGATTTAATA
GCTCCATGTCAACAAGAATAAAACGCGTTTCGGGTTTACCTCTTCCAGATACAGC
122 
TCATCTGCAATGCATTAATGCATTGGACCTCGCAACCCTAGTACGCCCTTCAGGC
TCCGGCGAAGCAGAAGAATAGCTTAGCAGAGTCTATTTTCATTTTCGGGAGACG
AGATCAAGCAGATCAACGGTCGTCAAGAGACCTACGAGACTGAGGAATCCGCT
CTTGGCTCCACGCGACTATATATTTGTCTCTAATTGTACTTTGACATGCTCCTCTTC
TTTACTCTGATAGCTTGACTATGAAAATTCCGTCACCAGCCCCTGGGTTCGCAAA
GATAATTGCACTGTTTCTTCCTTGAACTCTCAAGCCTACAGGACACACATTCATC
GTAGGTATAAACCTCGAAAATCATTCCTACTAAGATGGGTATACAATAGTAACCAT
GGTTGCCTAGTGAATGCTCCGTAACACCCAATACGCCGGCCGAAACTTTTTTACA
ACTCTCCTATGAGTCGTTTACCCAGAATGCACAGGTACACTTGTTTAGAGGTAAT
CCTTCTT 
 
3’flank (downstream of prd-1) 
AGGTCTCTGTCCTAGCTCGCTGTCTAAGTGATTGAGGTTGAATGTTTTGAGGTCT
ACGCTCAAGTAGATGTCTCGCTCAAGTGTGTACCTGTGACGATTTCCCAGAATTC
CTAGGGTAATTCAACGATTTGATTATGGAGTGCTCGCGATAAAGCTGTAGGTTTC
ACGTCGATGAGTCTTCTCTACGAGGTTAGTCCTTCACTTCCATATAGAAGATCAG
TATGAACATCTTTCTGATATATGTGTCTCGTAACATTCGACTTAATGCTCTGTACTT
TATGTTCGCAGAGTATTTCCTGTTCTACTCTCTCACTCTGAGGTACTGATTGACTG
TAGAGAAGCCGCTTGGCACGATTTGTGCTGCGTTCCAAGGTTAGTATGAATTGTG
TGCTTTGATATGTTAGTCTTGTGATTAGGTGAGAAAAATGAGCAACCTCCAACCA
CGTTTTGCGGGCTTCAGCGTCACGACTACTATAGTCTTATGATTCCGGTGTTGATT
TTGCTGAATGGCCATCAGGTTAACATATGGGCTCGAGTGTCTGCTGAGGTCCGAT
CGTCAAGTAACTAATGATGATGAGGAAGGAGCGATTCGAGGTAAGGAGAGAAC
GACTTGATGTTGGTGGGTCTCTGGCATTCACTGGGCACAGCACTGGGCACAGCC
CCAGTCCCCACTCTGTGCCCTGCCCAGACCGCACCATATCTAGCCTTCCAGATTC
GGCCAGTCTCCCTCTTCCTCTTTCTTCTCTATAGTACTTAATTAATTGTATCCAACC
123 
GCTTGATTTCGTTGGTGATCCTATAGGTTATGAGCCCTCTCTAACCTTCCTTGTAA
TTGTATTTAACGAGCGTATCCTTAAAGTGTATCGTCGGCTTCAATTGCCAATTTCA
ATAAGGCGCTATAGTACCGGGTTAAAAGAAGTAATGCGACCCTTATTGATTTAAC
GATTTGCCCGTTCGCCTATAAGCTAGTATTGCTATATGAAGATTCTCGTTAATATTT
GTTGTATAGCGACCCTATCGAATTAGTTATTAATTTATTTAATGAATTAATTATTGGT
TTATTTATTATCGAATTAAGTAATTTAAATAATTCTATTATCGAATTAATTAAATTAA
TTAATAGTTAGTCTAGCGATTACTAACTTCCTTCTTCTTAATATATTGTCGAACCCT
CCTATACCTACTATAATTACTAGTTCGTCGCTGGTTCCCCTCCTTGGCGATTAGAA
TATTGCCGATTAGTAATAGGGATTTATAGTTGAGTTTAATTGCTTTTAGTTCGCTAA
TTATATTTTCGAGATAGTTCTGGAGCCTAATAAAGCGATTGAGTCCGAGAAGTAC
AATACTTAGTGGATTAGATATACTAATATTAATAAGATTCTATTTTCTACCTTTAAG
AATACTGATGTTACTATTACTTTAAACGTTAATAGTTGGGATAGAACCGGTAGAG
ACCCTAAGGTTACGTA 
Probe Sequence: 
GAACTGGGACATGAGCGCTCTTCCCAAGTTCGAGAAGTCCTTCTACCAAGAGCA
TCCTAGCGTCGCCAACCGATCTCCTGCTGAGGTCGACAAGTTCCGCGCAGACCA
CTCCATTGCCGTCTTCGGTAACAACGTTCCCAAGCCTGTCGAGACCTTCGACGA
GGCTGGTTTCCCTCGCTACGTTATGGACGAGGTCAAGGCTCAGGGTTTCCCT 
 
gRNA: TCCCTTATTGTCATGCTTGCGGG 
TCTTGGGCTAGCGGTAAAGGTGCGCATTTTTTCACACCCTACAATGTTCTGTTCA
AAAGATTTTGGTCAAACGCTGTAGAAGTGAAAGTTGGTGCGCATGTTTCGGCGT
TCGAAACTTCTCCGCAGTGAAAGATAAATGATCGCCCTTATTGTCATGCTTGCgtttt
agagctagaaatagcaagttaaaataaggctagtccgttatcaacttgaaaaagtggcaccgagtcggtggtgctttttttgttttttatg
tctTCGAGTCATGTAATTAGTTATGTCACGCTTACgTTCACGCCCTCCCCCCACATC
CGCTCTAACCGAAAAGGAAGGAGTTAGACAACCTGAAGTCTAGGTCCCTATTTA
124 
TTTTTTTATAGTTATGTTAGTATTAAGAACGTTATTTATATTTCAAATTTTTCTTTTT
TTTCTGTACAGACGCGTGTACGCATGTAACATTATACTGAAAACCTTGCTTGAGA
AGGTTTTGGGACGCTCGAAGGCTTTAATTTGCGGCCGGTACCCAATTC 
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Appendix E: Mass Spectrometry Data 
Table a. Total spectrum counts of selected protein (4.3.3). Data from four independent experiments are shown. The vacant cells 
represent that proteins were undetectable. 
1 2 3 4 1 2 3 4 1 2 3 4
NCU00258 40S ribosomal protein S7 0 1 25 7 7
NCU00294 60S ribosomal protein L10a 1 23 2 6
NCU00413 60S ribosomal protein L2 3 4 4 46 8 1
NCU00475 40S ribosomal protein S18 1 2 3 14 8 7
NCU00634 60S ribosomal protein L14 1 4 2 23 5 7
NCU01221 60S ribosomal protein L16 1 3 1 23 3 1
NCU01452 40S ribosomal protein S1 1 4 4 1 11 1 31 6 11
NCU01552 ribosomal protein S28 1 2 2 22 1 4
NCU01776
60S ribosomal protein L15/
hypothetical protein GE21DRAFT_3246
0 3 28 3 3
NCU01827 60S ribosomal protein L27 1 6 1 6
NCU02181 40S ribosomal protein S4 1 18 6 2
NCU02707
60S ribosomal protein L6/
hypothetical protein GE21DRAFT_903
1 1 27 6 2
NCU03565 probable ribosomal protein L26 1 1 2 1 4 22 5 2
NCU03703 60S ribosomal protein L17 1 1 2 5 3 21 5 6
NCU03757 60S ribosomal protein L4-A 1 3 7 5 3 11 72 26 7
NCU04225 60S ribosomal protein L20 1 1 0 15 5 1
NCU04779 60S ribosomal protein L8 3 3 1 1 0 4 3 44 8 8
NCU05554 60S ribosomal protein L13 1 3 0 3 2 3 3 37 17 4
NCU05804 60S ribosomal protein L19 3 1 1 5 0 3 2 30 14 4
NCU06210 hypothetical protein GE21DRAFT_4187 2 3 1 34 5 3
NCU06432 40S ribosomal protein S12 4 1 1
NCU06843 60S ribosomal protein L3 1 2 2 1 36 4 6
NCU07735 Grp1p 0 0 4 5 1
NCU07829 60S ribosomal protein L7 1 27 13 4
NCU07830 40S ribosomal protein S14 5 2 1 23 5
NCU07839 ATP-dependent RNA helicase dbp-2 139 571 87 41
NCU08500 40S ribosomal protein S8 1 2 1 2 26 10 1
NCU08502 40S ribosomal protein S6 1 2 1 1 3 50 13 3
NCU08960
60S acidic ribosomal protein P1/
hypothetical protein
1 3 2 1 1 3 9 1
NCU08964 60S ribosomal protein L10 0 0 29 2 2
Gene ID Identified proteins
#26 (WT) #444 (NCU05950-FLAG) #588( PRD-1-FLAG)
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Table b. Percent coverage of selected protein (4.3.3). Data from four independent experiments are shown. The vacant cells represent 
that proteins were undetectable. 
1 2 3 4 1 2 3 4 1 2 3 4
NCU00258 40S ribosomal protein S7 16% 27% 53% 33% 28%
NCU00294 60S ribosomal protein L10a 9.70% 52% 17% 32%
NCU00413 60S ribosomal protein L2 16% 12% 16% 75% 19% 11%
NCU00475 40S ribosomal protein S18 4.50% 13% 28% 54% 35% 34%
NCU00634 60S ribosomal protein L14 8.50% 28% 9.20% 39% 29% 35%
NCU01221 60S ribosomal protein L16 6.90% 11% 4.00% 50% 16% 6.90%
NCU01452 40S ribosomal protein S1 5.50% 18% 16% 3.90% 31% 5.50% 62% 23% 37%
NCU01552 ribosomal protein S28 12% 25% 14% 53% 19% 38%
NCU01776
60S ribosomal protein L15/
hypothetical protein GE21DRAFT_3246
0.00% 13% 27% 22% 11%
NCU01827 60S ribosomal protein L27 13% 27% 5.90% 43%
NCU02181 40S ribosomal protein S4 4.60% 45% 34% 9.20%
NCU02707
60S ribosomal protein L6/
hypothetical protein GE21DRAFT_903
5.40% 5.90% 57% 20% 13%
NCU03565 probable ribosomal protein L26 15% 10% 15% 8.80% 27% 55% 34% 23%
NCU03703 60S ribosomal protein L17 6.50% 5.40% 10% 17% 22% 56% 32% 22%
NCU03757 60S ribosomal protein L4-A 3.90% 15% 23% 17% 15% 32% 72% 59% 24%
NCU04225 60S ribosomal protein L20 8.00% 8.00% 0.00% 34% 14% 10%
NCU04779 60S ribosomal protein L8 13% 16% 3.80% 4.60% 0.00% 14% 8.40% 63% 21% 24%
NCU05554 60S ribosomal protein L13 6.10% 15% 0.00% 16% 13% 18% 21% 67% 48% 18%
NCU05804 60S ribosomal protein L19 15% 9.40% 5.70% 24% 0.00% 13% 6.20% 37% 33% 13%
NCU06210 hypothetical protein GE21DRAFT_4187 8.00% 23% 8.00% 78% 25% 23%
NCU06432 40S ribosomal protein S12 21% 7.50% 6.80%
NCU06843 60S ribosomal protein L3 2.30% 2.30% 5.10% 2.30% 43% 15% 17%
NCU07735 Grp1p 0.00% 0.00% 8.50% 23% 3.70%
NCU07829 60S ribosomal protein L7 4.40% 57% 30% 15%
NCU07830 40S ribosomal protein S14 24% 15% 11% 65% 25%
NCU07839 ATP-dependent RNA helicase dbp-2 65% 98% 47% 35%
NCU08500 40S ribosomal protein S8 5.90% 5.90% 6.40% 5.90% 61% 39% 6.40%
NCU08502 40S ribosomal protein S6 8.40% 7.50% 5.90% 8.40% 13% 68% 44% 17%
NCU08960
60S acidic ribosomal protein P1/
hypothetical protein
16% 16% 16% 13% 16% 16% 51% 13%
NCU08964 60S ribosomal protein L10 0.00% 0.00% 75% 9.50% 9.50%
#26 (WT) #444 (NCU05950-FLAG) #588( PRD-1-FLAG)
Gene ID Identified proteins
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Table c. Exclusive unique peptide counts of selected protein (4.3.3). Data from four independent experiments are shown. The 
vacant cells represent that proteins were undetectable.
1 2 3 4 1 2 3 4 1 2 3 4
NCU00258 40S ribosomal protein S7 0 1 12 5 3
NCU00294 60S ribosomal protein L10a 1 11 2 5
NCU00413 60S ribosomal protein L2 3 2 2 22 6 1
NCU00475 40S ribosomal protein S18 1 2 3 11 6 5
NCU00634 60S ribosomal protein L14 1 3 1 11 4 5
NCU01221 60S ribosomal protein L16 1 2 1 14 2 1
NCU01452 40S ribosomal protein S1 1 4 4 1 7 1 22 5 8
NCU01552 ribosomal protein S28 1 2 2 10 1 4
NCU01776
60S ribosomal protein L15/
hypothetical protein GE21DRAFT_3246
0 2 7 3 2
NCU01827 60S ribosomal protein L27 1 4 1 4
NCU02181 40S ribosomal protein S4 1 12 5 2
NCU02707
60S ribosomal protein L6/
hypothetical protein GE21DRAFT_903
1 1 14 4 2
NCU03565 probable ribosomal protein L26 1 1 2 1 3 11 3 2
NCU03703 60S ribosomal protein L17 1 1 2 3 3 15 4 4
NCU03757 60S ribosomal protein L4-A 1 3 6 5 3 8 28 15 6
NCU04225 60S ribosomal protein L20 1 1 0 8 3 1
NCU04779 60S ribosomal protein L8 3 3 1 1 0 3 2 22 6 7
NCU05554 60S ribosomal protein L13 1 2 0 1 2 3 3 21 11 3
NCU05804 60S ribosomal protein L19 3 1 1 5 0 2 2 13 9 2
NCU06210 hypothetical protein GE21DRAFT_4187 1 3 1 15 3 3
NCU06432 40S ribosomal protein S12 4 1 1
NCU06843 60S ribosomal protein L3 1 1 1 1 17 3 5
NCU07735 Grp1p 0 0 2 5 1
NCU07829 60S ribosomal protein L7 1 13 7 3
NCU07830 40S ribosomal protein S14 4 2 1 12 4
NCU07839 ATP-dependent RNA helicase dbp-2 51 125 38 17
NCU08500 40S ribosomal protein S8 1 1 1 1 17 6 1
NCU08502 40S ribosomal protein S6 1 2 1 1 2 26 7 3
NCU08960
60S acidic ribosomal protein P1/
hypothetical protein
1 2 1 1 1 2 3 1
NCU08964 60S ribosomal protein L10 0 0 18 2 2
#26 (WT) #444 (NCU05950-FLAG) #588( PRD-1-FLAG)
Identified proteinsGene ID
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